{
  "$schema": "folio-library-entry/v1",
  "id": "9789241548960-eng",
  "blocks": [
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 2,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Handbook\nforGuideline \nDevelopment\n2nd edition\nWHO Library Cataloguing-in-Publication Data",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A cover page giving the title Handbook for Guideline Development, 2nd edition, followed by the start of the cataloguing-in-publication notice.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "WHO Handbook for Guideline Development",
      "pageStart": 2,
      "pageEnd": 11,
      "target": "../sections/sec-000-who-handbook-for-guideline-development.md",
      "narrative": null,
      "content": "1.Guidelines as Topic – standards. 2.Review. 3.Meta-Analysis. 4.Peer Review. 5.Evidence-Based \nMedicine. 6.World Health Organization. I.World Health Organization. \nISBN 978 92 4 154896 0\t\t\t\n(NLM classification: WA 39)\nAcknowledgements\nThis handbook was prepared by Susan L. Norris. Laragh Gollogly and Charles Penn provided advice and support throughout the \ndevelopment process. Contributions in the areas of equity, human rights, gender and social determinants were made in this edition \nof the handbook (including Chapter 5) by the WHO Gender, Equity and Human Rights mainstreaming team (acknowled",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Carries the publication front matter for the handbook: cataloguing data, acknowledgements naming the author, contributors, reviewers and funder, the copyright and disclaimer notices, and the full table of contents for the chapters. It then gives the foreword, which says the second edition adds more detailed guidance on each step plus two new chapters, one on equity, human rights, gender and social determinants and one on rapid advice guidelines in public health emergencies. The foreword also states that the guidance will be updated as methods evolve and invites feedback to the guideline review secretariat.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Foreword",
      "pageStart": 11,
      "pageEnd": 13,
      "target": "../sections/sec-001-foreword.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a WHO guideline?",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/sec-002-11-what-is-a-who-guideline.md",
      "narrative": null,
      "content": "A WHO guideline is any document developed by the World Health Organization containing recommendations for clinical practice or public health \npolicy. A recommendation tells the intended end-user of the guideline what \nhe or she can or should do in specific situations to achieve the best health \noutcomes possible, individually or collectively. It offers a choice among different interventions or measures having an anticipated positive impact on \nhealth and implications for the use of resources.\nRecommendations help the user of the guideline to make informed decisions on whether to undertake spec",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a WHO guideline as any WHO document containing recommendations for clinical practice or public health policy. Explains that a recommendation tells the intended user what to do in specific situations to achieve the best health outcomes and helps users decide, select and prioritize among interventions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Why does WHO develop guidelines?",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/sec-003-12-why-does-who-develop-guidelines.md",
      "narrative": null,
      "content": "WHO develops guidelines whenever Member States, WHO country offices, \nexternal experts or other stakeholders ask for guidance on a clinical or public \nhealth problem or policy area. This generally happens when they are uncertain \nabout what to do or how to choose among a range of potential policies or interventions. Uncertainty can be triggered by a new public health problem or emergency; the uncovering of new evidence; an absence of good-quality evidence (or \nof any evidence at all); or a change in resource availability or access to services.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that WHO develops guidelines when Member States, country offices, experts or other stakeholders ask for guidance because they are unsure what to do. Lists the triggers of such uncertainty: a new problem or emergency, new evidence, a lack of good evidence, or a change in resources or access to services.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What principles underlie WHO guidelines?",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/sec-004-13-what-principles-underlie-who-guidelines.md",
      "narrative": null,
      "content": "The Twelfth General Programme of Work (GPW) of WHO (2014) specifies \nthat in its normative and standard-setting work, WHO is and will remain \na science- and evidence-based organization with a focus on public health. \nGuidelines are the fundamental means through which the Organization fulfils its technical leadership in health, as identified in the GPW. The GPW \nstates that “WHO’s legitimacy and technical authority lie in its rigorous \nadherence to the systematic use of evidence as the basis for all policies” (1).",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the principle that WHO is a science- and evidence-based organization, citing its general programme of work. States that guidelines are the main means of exercising technical leadership and that WHO's authority rests on systematic use of evidence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 13,
      "pageEnd": 14,
      "target": "../sections/sec-005-1-introduction.md",
      "narrative": null,
      "content": "1\n2\nWHO has adopted internationally recognized methods and standards \nfor guideline development to ensure that its guidelines are of the highest \nquality. WHO guidelines must be developed in observance of the following \nprinciples:\n■■\nGuidelines address an area of uncertainty and an unmet need for \nguidance.\n■■\nGuidelines reflect the core WHO value of the “right to health” (2).\n■■\nThe process of developing recommendations is explicit and transparent: the user can see how and why a recommendation was developed, \nby whom, and on what basis.\n■■\nThe process of developing guidelines is multidiscipl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the principles WHO guidelines must follow, after noting that WHO uses internationally recognized methods and standards. The principles include addressing a real area of uncertainty, reflecting the right to health, transparent and explicit development, multidisciplinary input, minimizing bias, systematic weighing of benefits and harms, public availability of evidence, adaptability to local settings, and tailoring to a specific audience.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the aim of this handbook?",
      "pageStart": 14,
      "pageEnd": 15,
      "target": "../sections/sec-006-14-what-is-the-aim-of-this-handbook.md",
      "narrative": null,
      "content": "This handbook presents the important principles of guideline development \nand provides stepwise instruction on the technical and procedural aspects \nof developing a WHO guideline. It aims to steer readers through the process to ensure that the resulting guideline is credible; the recommendations \naccurately reflect the balance of potential benefits and harms; the guideline \nmeets WHO’s publication standards in terms of content, methods and presentation; the underlying evidence is accessible; and the recommendations \nare implementable and positive in their impact on population health.\nChapter 1",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States the aim of the handbook: to set out principles and stepwise instruction for developing a WHO guideline. Says the goal is a credible guideline whose recommendations balance benefits and harms, meet WHO publication standards, rest on accessible evidence and can be implemented to benefit population health.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "For whom is this handbook intended?",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/sec-007-15-for-whom-is-this-handbook-intended.md",
      "narrative": null,
      "content": "This handbook is intended for:\n■■\nany WHO department, programme or staff member wishing to produce a guideline;\n■■\nmembers of a WHO guideline steering group;\n■■\nmembers of a WHO guideline development group (GDG);\n■■\nmembers of a WHO guideline external review group; and\n■■\nanyone interested in understanding how WHO develops guidelines.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the intended readers of the handbook: WHO staff and departments wishing to produce a guideline, members of the steering, development and external review groups, and anyone wanting to understand how WHO develops guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is in this handbook?",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/sec-008-16-what-is-in-this-handbook.md",
      "narrative": null,
      "content": "This handbook follows the entire development of a WHO guideline − from determining if a guideline is needed through to eventual publication. The guideline \ndevelopment process and its primary contributors are summarized in Table 1.1.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the handbook follows guideline development from deciding whether a guideline is needed through to publication, and points to a table summarizing the process and its main contributors.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Types of WHO guidelines",
      "pageStart": 15,
      "pageEnd": 18,
      "target": "../sections/sec-009-17-types-of-who-guidelines.md",
      "narrative": null,
      "content": "It is important to consider what type of guideline will best fit the intended \npurpose, as this will determine the methods, resources and time frame for \ndevelopment, finalization and dissemination (see Table 1.2). WHO guidelines comprise a broad spectrum of products that vary mainly in terms of \nthe following features:\n■■\npurpose;\n■■\nscope;\n■■\nthe point in time at which the guideline is being developed relative to \nthe life-span of an intervention;\n■■\nthe organizations or entities developing the guideline;\n■■\nthe presence in the guideline of new versus previously published recommendations; an",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the type of guideline determines methods, resources and time frame, and that types differ in purpose, scope, timing, developer, new versus existing recommendations and timeline. Names four main types (standard, consolidated, interim, and emergency or urgent-need) plus other less frequent types. Presents a table of the development process by stage, contributor, step and chapter, from planning through publishing and updating, and a table comparing each type's purpose, scope, developer, recommendations and development period.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Standard guidelines",
      "pageStart": 18,
      "pageEnd": 18,
      "target": "../sections/sec-010-171-standard-guidelines.md",
      "narrative": null,
      "content": "A standard guideline covers a clinical or policy area (e.g. the treatment \nof postpartum haemorrhage or the minimum requirements for the safe \ndelivery of care to people with HIV infection). Such guidelines vary \ngreatly in scope and focus: they might address the use of a single drug \nfor a disease or condition, such as naloxone injection by lay persons for \nsuspected opioid overdose, or they might encompass the full scope of a \ncondition or public health problem, such as the diagnosis, screening and \ntreatment of type 2 diabetes mellitus. Recommendations in a standard \nguideline are either de",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes standard guidelines, which cover a clinical or policy area and can range from a single drug to the full scope of a condition, with recommendations either new or updated. Lists their usual focus areas such as clinical interventions, health-system policy, public health exposures, diagnostic tests and surveillance, and states they typically take 9 to 24 months, need systematic reviews and one or two group meetings, and have a review date. Notes that most WHO guidelines are of this type.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Consolidated guidelines",
      "pageStart": 18,
      "pageEnd": 19,
      "target": "../sections/sec-011-172-consolidated-guidelines.md",
      "narrative": null,
      "content": "A consolidated guideline (also known as a compilation of guidelines) contains recommendations from existing WHO guidelines, or from guidelines \nproduced by other organizations that have followed processes consistent \nChapter 1 \n Introduction\n7\nwith those used by WHO (see Section 1.8.2). Producing consolidated guidelines is complex because existing guidelines may need to be updated and \nnew recommendations may have to be added to address important gaps in \nthe existing guidance. In addition, maintaining the document is difficult, \nsince individual recommendations may become outdated at differen",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a consolidated guideline as a compilation of recommendations from existing WHO guidelines or from other organizations' guidelines produced by consistent processes. Explains that it is complex to produce and maintain, that all included recommendations must be up to date and approved by the review committee, and that cross-referencing is required. Sets out when committee review is needed and the one case in which it is not.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Interim guidelines",
      "pageStart": 19,
      "pageEnd": 20,
      "target": "../sections/sec-012-173-interim-guidelines.md",
      "narrative": null,
      "content": "Interim guidelines are produced when WHO is asked to provide guidance when \nthe available data and information are most certainly incomplete, especially if \nadditional data are anticipated in the near future. This can occur when an intervention − a drug, a medical device or a health practice, for example − has just \nappeared or is about to be made available; a new disease or condition has emerged; \nor new data on an existing intervention, exposure, disease or condition have been \nreported. Interim guidelines usually have a very focused scope and a short shelf-\nlife. They should always clearly",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes interim guidelines, produced when guidance is requested while data are incomplete, for example for a new intervention, disease or data. Says they have a narrow scope and short shelf-life, must state when more evidence is expected, and still comply fully with the handbook's processes and standards despite pressure for speed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guidelines in response to an emergency or urgent need",
      "pageStart": 20,
      "pageEnd": 21,
      "target": "../sections/sec-013-174-guidelines-in-response-to-an-emergency-or-ur.md",
      "narrative": null,
      "content": "Certain circumstances preclude the development of a standard guideline. This is \nthe case when WHO must provide guidance in response to public health emergencies. Depending on the type of event or situation, such guidelines may need to \nbe produced within hours, days, weeks or months. Their purpose and the methods used to develop them vary with the time frame in which guidance is required.\nAlthough guidelines that must be produced rapidly cover a wide spectrum, it is convenient to consider two basic types:\n■■\nEmergency (rapid response) guidelines ‒ Public health emergencies \nmay necessitate a",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes guidelines produced for emergencies or urgent need and distinguishes two basic kinds. Emergency (rapid response) guidelines may rely on existing guidelines or expert opinion within hours to days but must still keep basic quality principles and document their rationale. Rapid advice guidelines follow WHO processes more closely, carry a review-by date and need committee review at both stages. Also notes that urgent recommendations outside an emergency must rest on a systematic review and meet all handbook standards.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Additional types of guidelines produced by WHO",
      "pageStart": 21,
      "pageEnd": 21,
      "target": "../sections/sec-014-18-additional-types-of-guidelines-produced-by-wh.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guidelines developed in collaboration with external organizations",
      "pageStart": 21,
      "pageEnd": 22,
      "target": "../sections/sec-015-181-guidelines-developed-in-collaboration-with-e.md",
      "narrative": null,
      "content": "organizations\nClinical and public health guidelines are produced by many organizations, \nincluding national agencies, intergovernmental organizations and specialist \nmedical societies. From time to time it may be appropriate for WHO to col-\nlaborate with these groups to produce a joint guideline.\nCollaborative guidelines must adhere to the basic principles for WHO \nguidelines. When developing such guidelines, it is particularly important to \nnote that:\n■■\nno funding can come from commercial sources, and conflicts of interest must be declared and managed as per WHO procedures;\n■■\na systematic r",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how WHO may jointly produce guidelines with external organizations, which must still follow WHO's basic principles. Lists requirements including no commercial funding, managed conflicts of interest, a systematic review, transparent methods, representative experts and consultation on publishing. States that staff must submit a planning proposal highlighting any deviation, which the review committee assesses case by case.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guidelines developed by external organizations",
      "pageStart": 22,
      "pageEnd": 22,
      "target": "../sections/sec-016-182-guidelines-developed-by-external-organizatio.md",
      "narrative": null,
      "content": "Guidelines that serve WHO’s purpose may already exist and WHO may consider adopting, adapting or incorporating all or part of a guideline developed \nby an external organization. In order to adopt or endorse such a guideline, \nWHO staff in the relevant technical unit must carefully evaluate the guideline’s quality and applicability to WHO’s needs.\nThe guideline must meet WHO’s standards for guidelines as depicted \nin this handbook. The two standards that externally developed guidelines \ncan seldom meet are: (a) applicability to a global target audience (most notably low- and middle-income count",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Covers guidelines developed by external organizations that WHO might adopt, adapt or incorporate, which requires careful evaluation of quality and applicability. Says such guidelines rarely meet two standards, global applicability and expert panels representing all WHO regions, so adoption is rare. Specifies what the planning proposal for an endorsed or adapted guideline must contain.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Adaptation of existing WHO guidelines",
      "pageStart": 22,
      "pageEnd": 23,
      "target": "../sections/sec-017-183-adaptation-of-existing-who-guidelines.md",
      "narrative": null,
      "content": "WHO guidelines originally intended for one setting may be adapted for use \nin another. For example, guidelines on routine obstetric care can be adapted \nfor emergency settings. Adaptations of WHO guidelines must follow standard GRC procedures, including GRC review of the planning proposal and the \nfinal guideline. Guidelines may also be adapted in emergency or urgent situations, when existing guidelines need to be quickly identified and assessed. \nThe GRC Secretariat is developing further guidance on when and how to \nadapt existing guidelines in such situations.\nChapter 1 \n Introduction\n11",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that WHO guidelines made for one setting may be adapted to another, for example routine obstetric care adapted for emergency settings. States that adaptations follow standard review-committee procedures and that further guidance on adapting in urgent situations is being developed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Information products that are not considered guidelines",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../sections/sec-018-19-information-products-that-are-not-considered.md",
      "narrative": null,
      "content": "guidelines\nCertain types of documents are not considered guidelines and do not need \nto be submitted to the GRC for review. They include:\n■■\ndocuments that state established principles (e.g. human rights, WHO \nconstitutional issues);\n■■\nWHO Secretariat reports and other papers submitted to the Governing Bodies (Executive Board, Regional Committees, World Health \nAssembly);\n■■\ninformation documents that report facts, describe evidence, or document or review existing practices and interventions, provided that such \ndocuments are not making recommendations or advocating commitment of resources;\n■",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists document types that are not considered guidelines and need no committee review, such as statements of established principles, governing-body reports, purely informational documents, manufacturing standards, operational how-to manuals and standard operating procedures. Advises consulting the committee secretariat when unsure.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The Guideline Review Committee",
      "pageStart": 23,
      "pageEnd": 24,
      "target": "../sections/sec-019-110-the-guideline-review-committee.md",
      "narrative": null,
      "content": "The GRC was established by WHO’s Director-General in 2007 to ensure that \nWHO guidelines are of high quality, that they are developed using a transparent and explicit process, and that, to the extent possible, recommendations are based on evidence (3).\nThe GRC is composed of approximately 30 individuals, including representatives from all WHO regions as well as external members, and meets \nmonthly to review submitted documents.\n12",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the Guideline Review Committee, established by the Director-General in 2007 to ensure WHO guidelines are high quality, transparently developed and evidence-based. Says it has about 30 members from all WHO regions plus external members and meets monthly.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Terms of reference of the GRC",
      "pageStart": 24,
      "pageEnd": 25,
      "target": "../sections/sec-020-1101-terms-of-reference-of-the-grc.md",
      "narrative": null,
      "content": "All WHO publications containing recommendations must be approved by \nthe GRC according to WHO policies and procedures (4). The GRC reviews \nevery WHO guideline twice during its development – once at the initial \nplanning stage and again after the recommendations have been developed \nand the guideline document has been finalized and edited.\nThe review of a planning proposal includes an assessment of whether \nthe proposed guideline development process is consistent with the steps \ndescribed in this handbook. The review of final submissions ensures that \nthe approved process has been followed and",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the committee's terms of reference: it must approve all WHO publications containing recommendations and reviews each guideline twice, at the planning stage and after the final document is edited. Explains what each review checks, that the committee advises on process and methods but not technical content, and how its approval fits into WHO's internal clearance sequence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The GRC Secretariat",
      "pageStart": 25,
      "pageEnd": 25,
      "target": "../sections/sec-021-1102-the-grc-secretariat.md",
      "narrative": null,
      "content": "The GRC Secretariat has several important roles. In addition to supporting \nthe GRC, it provides WHO staff with technical advice on guideline development, sets benchmarks, and evaluates guideline development processes, \ndocuments and standards to achieve quality assurance and improvement for \nWHO guidelines. More specifically, the GRC Secretariat:\n■■\ncoordinates and provides technical support on guideline development \nto WHO technical units at headquarters and in the regional offices;\n■■\norganizes training on guideline development methods and procedures for WHO staff;\n■■\nprovides administrativ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the roles of the review committee secretariat, which supports the committee, advises WHO staff, sets benchmarks and evaluates guideline processes for quality assurance. Itemizes its tasks, including coordinating technical support, organizing training, collaborating with methodological networks and keeping a database of submissions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 25,
      "pageEnd": 27,
      "target": "../sections/sec-022-111-references.md",
      "narrative": null,
      "content": "1.\t\nTwelfth General Programme of Work: not merely the absence of disease. Geneva: World \nHealth Organization; 2014 (http://www.who.int/about/resources_planning/twelfth-gpw/\nen, accessed 11 November 2014).\n2.\t\nConstitution of the World Health Organization. Geneva: World Health Organization; 1946 \n(http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf, accessed 11 November 2014).\n3.\t\nInformation Note - Establishment of a WHO Guidelines Review Committee [intranet site: \navailable to WHO staff only]. Geneva: World Health Organization; 2007 (http://intranet.\nwho.int/admin/infonotes/documents/16",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A numbered list of six references for Chapter 1, covering the general programme of work, the WHO Constitution, the committee's establishment note and WHO manual and intranet pages. The extraction also includes the opening sentence of Chapter 2 on the value of early planning.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is this guideline really needed?",
      "pageStart": 27,
      "pageEnd": 27,
      "target": "../sections/sec-023-21-is-this-guideline-really-needed.md",
      "narrative": null,
      "content": "When planning to develop a guideline, you must begin by asking a critical question: Is this guideline really needed? Guideline development is time-\nconsuming and expensive. You must carefully consider several issues before \nembarking on the process.\nPriority-setting in the normative work at WHO needs continuous evaluation and revision as priorities evolve within and across technical units. \nRequests for guidelines exceed the number of guidelines that can be produced with available resources. In keeping with the need to prioritize, be \nsure to ask certain key questions before deciding to develo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opens the question of whether a guideline is really needed, noting that development is time-consuming and expensive and that requests exceed capacity. Advises asking key questions before deciding to proceed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who wants the guideline?",
      "pageStart": 27,
      "pageEnd": 27,
      "target": "../sections/sec-024-211-who-wants-the-guideline.md",
      "narrative": null,
      "content": "Have one or more WHO Member States requested it? WHO guidelines must \ngenerally meet global or regional needs and have a public health perspective.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks whether Member States have requested the guideline, noting that WHO guidelines should generally meet global or regional needs and take a public health perspective.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Should WHO be the organization to produce this guideline?",
      "pageStart": 27,
      "pageEnd": 27,
      "target": "../sections/sec-025-212-should-who-be-the-organization-to-produce-th.md",
      "narrative": null,
      "content": "Have WHO’s governing bodies requested the guideline? Is WHO in the best \nposition to issue guidance on this topic? Does the topic fall within the scope",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Poses questions on whether governing bodies requested the guideline and whether WHO is best placed to issue guidance on the topic; the text breaks off mid-sentence because of the page split.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Planning guidelines",
      "pageStart": 27,
      "pageEnd": 28,
      "target": "../sections/sec-026-2-planning-guidelines.md",
      "narrative": null,
      "content": "15\nWHO handbook for guideline development\n16\nline owing to its resources, implementation skills and experience, or its local \nand regional knowledge?\n2.1.3 Do guidelines on the topic already exist? \nHave guidelines on the same topic already been issued by other departments at WHO or by other organizations? Do they address the needs of \nWHO’s Member States? Avoid duplicating existing work by consulting \nthe relevant departments, the GRC Secretariat and the WHO library. \nIf existing guidelines are identified, examine their quality and applicability to the current need. Consider updating existing",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Mixes the end of the question on whether WHO should produce a guideline, which refers to its resources, implementation skills and local knowledge, with the section on whether guidelines on the topic already exist. Advises consulting WHO departments, the review committee secretariat and the library to avoid duplication, and examining or updating existing guidelines that are out of date.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What purpose and audience does the guideline serve?",
      "pageStart": 28,
      "pageEnd": 28,
      "target": "../sections/sec-027-22-what-purpose-and-audience-does-the-guideline.md",
      "narrative": null,
      "content": "WHO staff developing guidelines need to have a clear goal and audience in \nmind when they set about developing a guideline.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the section on purpose and audience, stating that staff need a clear goal and audience in mind when developing a guideline.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What will the guideline achieve?",
      "pageStart": 28,
      "pageEnd": 28,
      "target": "../sections/sec-028-221-what-will-the-guideline-achieve.md",
      "narrative": null,
      "content": "Will the guideline address poor practice or change programme approaches \nor health policy while aiming to fulfil the right to health? Will the guideline \nprovide direction for users in areas in which they feel uncertain about what \nto do? Resolving uncertainty should be the focus of most guidelines.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Poses questions about what a guideline will achieve, such as addressing poor practice or changing programmes or policy while fulfilling the right to health. States that resolving users' uncertainty should be the focus of most guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What are the specific objectives of the guideline?",
      "pageStart": 28,
      "pageEnd": 29,
      "target": "../sections/sec-029-222-what-are-the-specific-objectives-of-the-guid.md",
      "narrative": null,
      "content": "What health indicators or other measures do you hope to improve? What test \nor approach do you wish to evaluate and provide guidance on? Clear, achievable objectives will govern and facilitate the development of your guideline.\nChapter 2 \nPlanning guidelines\n17",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks what health indicators, tests or approaches a guideline targets and says clear, achievable objectives will govern and facilitate its development.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-030",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who is the target audience?",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../sections/sec-030-223-who-is-the-target-audience.md",
      "narrative": null,
      "content": "Guidelines must have a clearly defined target audience (end-user) which is \nidentified early in the guideline development process, and the recommendations need to be tailored to that audience. (Note that the end-users are those \nwho will apply the guidelines, not the recipients of the recommended interventions.) Writing documents to meet the needs of policy-makers, health-\nsector managers, clinicians and other health professionals simultaneously is \nnot straightforward and should be avoided.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that a guideline needs a clearly defined target audience identified early, with recommendations tailored to it. Clarifies that end-users apply the guideline while recipients receive the interventions, and warns against writing for policy-makers, managers and clinicians at once.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-031",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who are the recipients of the interventions?",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../sections/sec-031-224-who-are-the-recipients-of-the-interventions.md",
      "narrative": null,
      "content": "Who are the service users and other individuals whose health and well-being will \nbe affected by the recommended interventions? Attention to their perspectives and \nneeds must be built into the guideline development process from the beginning.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks who the service users and other recipients of the recommended interventions are, and says their perspectives and needs must be built into guideline development from the beginning.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-032",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "When is the guideline needed?",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../sections/sec-032-23-when-is-the-guideline-needed.md",
      "narrative": null,
      "content": "The optimal time to start developing a guideline and the time frame for completing the task must be carefully considered at the outset.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the best start time and the completion time frame for a guideline must be considered carefully at the outset.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-033",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Why now?",
      "pageStart": 29,
      "pageEnd": 30,
      "target": "../sections/sec-033-231-why-now.md",
      "narrative": null,
      "content": "Is this the best time to develop recommendations, or are new data expected \nto emerge in the near future? Will the existing infrastructure or policies \nchange in a manner likely to affect guideline implementation?\n2.3.2 When is the guideline needed? \nThe projected timeline for guideline development needs to be matched with \nthe time when the guidance is needed. Realistically, a high-quality standard \nguideline will take at least 9 to 12 months to produce if it has a fairly narrow \nscope. On the other hand, if the guideline aims to cover a large number of \nquestions and involves many de novo sy",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks whether now is the best time to develop recommendations, given expected new data or changes in infrastructure or policy that could affect implementation. Also says the timeline must match when guidance is needed, with a narrow high-quality standard guideline taking at least 9 to 12 months and a broad one with many new systematic reviews taking 2 to 3 years.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-034",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is the guideline a response to a situation calling for urgent advice?",
      "pageStart": 30,
      "pageEnd": 30,
      "target": "../sections/sec-034-233-is-the-guideline-a-response-to-a-situation-c.md",
      "narrative": null,
      "content": "advice? \nIf so, the guideline development process and methods may differ from those \nused for standard guidelines. Under a compressed timeline, the scope of \na guideline may have to be greatly reduced. In addition, rapid review and \nguideline development processes and methods can result in an end product \nwith a high risk of bias. WHO staff must balance this risk with the demand \nto produce recommendations rapidly (see Chapter 11).",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that a guideline responding to urgent advice needs different processes and methods, often a greatly reduced scope. Warns that rapid methods carry a high risk of bias, which staff must balance against the demand for speed, and refers to Chapter 11.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-035",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Will the recommendations in the guideline be implemented?",
      "pageStart": 30,
      "pageEnd": 30,
      "target": "../sections/sec-035-24-will-the-recommendations-in-the-guideline-be.md",
      "narrative": null,
      "content": "implemented?\nThe purpose of WHO guidelines is to improve the health and well-being of \nindividuals and populations. To accomplish that, guidelines need to be disseminated, adopted or adapted, and their recommendations implemented.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that guidelines aim to improve health and therefore must be disseminated, adopted or adapted, and implemented. Introduces the question of whether recommendations will actually be implemented.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-036",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Are the guideline and its implementation within the relevant programme’s work area and budget?",
      "pageStart": 30,
      "pageEnd": 30,
      "target": "../sections/sec-036-241-are-the-guideline-and-its-implementation-wit.md",
      "narrative": null,
      "content": "programme’s work area and budget?\nUnder the WHO reform (1) all work at WHO should fall within the scope of the \nGeneral Programme of Work and Programme Budget, as agreed with WHO’s \nGoverning Bodies. If the guideline does not fall within this remit, it will be difficult to justify the resources and budget needed to complete the work.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that under WHO reform all work must fall within the General Programme of Work and Programme Budget, so a guideline outside that remit will be hard to justify in resources and budget.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-037",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is a process for disseminating and implementing the recommendations in place?",
      "pageStart": 30,
      "pageEnd": 31,
      "target": "../sections/sec-037-242-is-a-process-for-disseminating-and-implement.md",
      "narrative": null,
      "content": "recommendations in place?\nWho is likely to implement the recommendations? What level of guidance \nis needed and in what format? What infrastructure and services are needed \nfor implementation? Is access to the service an important consideration? \nThese issues should be considered from the start, as they affect who should \nbe involved, what resources are required and how the recommendations are \ncrafted and presented.\nChapter 2 \nPlanning guidelines\n19",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Poses questions about who will implement the recommendations, what level and format of guidance is needed, and what infrastructure, services and access are required. Says these issues should be considered from the start because they affect who is involved, resources and how recommendations are written.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-038",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who should be involved in developing a guideline?",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-038-25-who-should-be-involved-in-developing-a-guidel.md",
      "narrative": null,
      "content": "Guideline development involves collaboration among a large number of \ngroups and people (see Chapter 3). These should be engaged from the outset.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says guideline development involves many groups and people, referring to Chapter 3, and that they should be engaged from the outset.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-039",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Do you have your director’s agreement?",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-039-251-do-you-have-your-directors-agreement.md",
      "narrative": null,
      "content": "You will need your director’s formal approval before your planning proposal or \nyour final guideline can be considered by the GRC. In addition, your ADG will \nneed to approve the final guideline after its review and approval by the GRC.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the director's formal approval is needed before the planning proposal or final guideline goes to the review committee, and that the assistant director-general must approve the final guideline afterwards.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-040",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What WHO departments must be involved?",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-040-252-what-who-departments-must-be-involved.md",
      "narrative": null,
      "content": "Do other departments at headquarters or in WHO’s regional offices, including those with cross-cutting mandates, have an interest in the guideline, \nhave relevant expertise or are producing similar products? Prepare a list \nof technical units at WHO and of key external organizations, experts and \nstakeholders that will need to be consulted or involved in the guideline \ndevelopment process.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks which other headquarters and regional departments, including those with cross-cutting mandates, have interest, expertise or similar products. Advises preparing a list of WHO technical units and external organizations, experts and stakeholders to consult.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-041",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Have you identified experts in guideline methods?",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-041-253-have-you-identified-experts-in-guideline-met.md",
      "narrative": null,
      "content": "Generally WHO staff commission systematic review and guideline development experts to assist in formulating the key questions; identifying, \nassessing and synthesizing the evidence; and translating the evidence into \nrecommendations. Such experts should be identified early in the guideline \ndevelopment process.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says WHO staff usually commission experts in systematic reviews and guideline development to help with key questions, evidence work and turning evidence into recommendations, and that they should be identified early.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-042",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Additional considerations",
      "pageStart": 31,
      "pageEnd": 32,
      "target": "../sections/sec-042-26-additional-considerations.md",
      "narrative": null,
      "content": "Once you are certain that a guideline is needed by its intended end-users \nand will benefit the service users or other recipients of the recommended \nmeasures or interventions, you need to consider several other factors before \nembarking on the project.\nWHO handbook for guideline development\n20",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces further factors to consider once a guideline is judged needed by its end-users and beneficial to recipients, before starting the project.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-043",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Do you have the necessary resources to develop a guideline?",
      "pageStart": 32,
      "pageEnd": 32,
      "target": "../sections/sec-043-261-do-you-have-the-necessary-resources-to-devel.md",
      "narrative": null,
      "content": "To produce a high-quality guideline, you will need resources to identify or \nperform systematic reviews, convene meetings and cover production costs. \nNote that WHO cannot develop guidelines using money from commercial \nentities (see Chapter 6). Guideline development also involves long hours of \ndedication by WHO staff.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks whether resources are sufficient for systematic reviews, meetings and production costs. Notes that WHO cannot use commercial money for guidelines and that development demands long hours from staff.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-044",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What publication types and formats are you considering?",
      "pageStart": 32,
      "pageEnd": 32,
      "target": "../sections/sec-044-262-what-publication-types-and-formats-are-you-c.md",
      "narrative": null,
      "content": "What level of detail and format will your target audience find most useful? \nGuideline users are not generally interested in a detailed description of how \nguidelines are developed to conform to WHO standards, so you should plan \nand budget for derivative products such as summaries, algorithms or wall \ncharts specifically tailored for the end-users of the guideline. Electronic versions, perhaps accompanied by short paper publications, may be more practical and cheaper than print versions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises considering the level of detail and format that users want, and budgeting for derivative products such as summaries, algorithms or wall charts, since users rarely want detail on methods. Suggests electronic versions with short paper publications may be cheaper and more practical.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-045",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What translations are you planning?",
      "pageStart": 32,
      "pageEnd": 32,
      "target": "../sections/sec-045-263-what-translations-are-you-planning.md",
      "narrative": null,
      "content": "What languages are spoken by the people most in need of the advice in your \nguideline? Consider the implications for your budget and time frame and \ncarefully choose the language(s) for the translation of your guideline.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Asks which languages are spoken by those most in need of the advice and says to weigh translation implications for budget and timeline when choosing languages.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-046",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Scoping the guideline",
      "pageStart": 32,
      "pageEnd": 33,
      "target": "../sections/sec-046-27-scoping-the-guideline.md",
      "narrative": null,
      "content": "Scoping is the process of defining what the guideline will and will not include. \nTo establish the scope, you need to determine:\n■■\nthe areas of practice or policy to which the guideline applies;\n■■\nthe interventions, approaches or exposures of interest (i.e. the priority \ntopics);\nChapter 2 \nPlanning guidelines\n21\n■■\nthe individuals and/or populations (including subpopulations) that the \nrecommendations are intended to affect; and\n■■\nthe important outcomes − both benefits and harms – that may result.\nThe process of scoping a guideline will establish the focus for the recommendations, as well",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines scoping as deciding what a guideline will and will not include, and lists what must be determined: areas of practice or policy, interventions or exposures, affected populations and important benefit and harm outcomes. Explains that scoping sets the focus and key questions and keeps the guideline manageable, and calls it one of the hardest and most important steps because a wrong scope wastes resources and leaves users uncertain.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-047",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How to scope the guideline",
      "pageStart": 33,
      "pageEnd": 34,
      "target": "../sections/sec-047-271-how-to-scope-the-guideline.md",
      "narrative": null,
      "content": "Scoping a guideline involves a series of steps, generally performed or coordinated by the responsible technical officer.\n■■\nDraft the potential scope ‒ Draft a proposed scope and a list of potential priority topics.\n■■\nSet up the WHO guideline steering group (“steering group” for the \nremainder of the text) ‒ Convene a small group of WHO staff, including representatives of all relevant departments, to provide feedback on \nthe proposed scope of the guideline.\n■■\nRefine the list of priority topics ‒ Identify the key issues: this determines the breadth and depth of the work. Do not try to include",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the steps of scoping, coordinated by the responsible technical officer: draft the scope, set up the steering group, refine priority topics, run a preliminary literature search, keep the topic list minimal, and formulate key questions in the population, intervention, comparator and outcome format. Stresses avoiding a textbook-style scope, focusing on areas of desired change, inequity, controversy or uncertainty, and considering equity, human rights and gender early.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-048",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The steering group",
      "pageStart": 34,
      "pageEnd": 34,
      "target": "../sections/sec-048-31-the-steering-group.md",
      "narrative": null,
      "content": "scope, a summary of the scope should be circulated to the GDG and \nsometimes other stakeholders for comments. These groups should be \nreminded that WHO is producing a guideline, not a textbook, as the \nreviewers will almost invariably suggest expanding the planned scope.\n■■\nReconsider ‒ Once you have incorporated the external feedback as \nappropriate, review the scope and key questions again. Is the scope feasible? Is the time frame reasonable? Are sufficient financial and human \nresources available?",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Despite its heading, contains the closing steps of the scoping procedure: circulating a scope summary to the development group and other stakeholders while reminding them that a guideline is not a textbook, and then reconsidering feasibility, time frame and resources after feedback.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-049",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 34,
      "pageEnd": 36,
      "target": "../sections/sec-049-28-references.md",
      "narrative": null,
      "content": "1.\t\nWHO reform [website]. Geneva: World Health Organization; 2014 (http://www.who.int/\nabout/who_reform/en, accessed 11 November 2014).\nWhen developing WHO guidelines, four groups need to be established \n(Table 3.1):\n■■\nthe steering group;\n■■\nthe GDG;\n■■\nthe external review group; and\n■■\nthe systematic review team.\nThese groups have different skills, perspectives, roles, responsibilities \nand tasks. They are established at different times, but all work to produce a \nhigh-quality guideline.\n3.1 The steering group\nOnce the technical unit has decided to proceed with developing a guideline, \nthe s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Begins with a single reference on WHO reform, then opens Chapter 3 by naming the four groups to be established: the steering group, the guideline development group, the external review group and the systematic review team. Describes the steering group's composition, size and time commitment, and lists its roles, from drafting the scope and managing conflicts of interest to organizing meetings, drafting the guideline, overseeing review and publication, and monitoring the need for updates.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-050",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The guideline development group",
      "pageStart": 36,
      "pageEnd": 37,
      "target": "../sections/sec-050-32-the-guideline-development-group.md",
      "narrative": null,
      "content": "The GDG is made up of external experts whose central task is to develop evidence-based recommendations. The GDG also performs the important task \nof finalizing the scope and key questions of the guideline in PICO format. \nThis group should be established early in the guideline development process, \nonce the steering group has defined the guideline’s general scope and target \naudience and begun drafting the key questions.\nPotential members of the GDG are identified by the steering group and \nare selected to encompass the technical skills, diverse perspectives and geographic representation neede",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the guideline development group as external experts who develop evidence-based recommendations and finalize the scope and key questions. Explains when it is established, how members are chosen for skills, diversity and geography, the usual size of 10 to 20, and that it normally needs at least one face-to-face meeting.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-051",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Contributors and their role in guideline development",
      "pageStart": 37,
      "pageEnd": 37,
      "target": "../sections/sec-051-3-contributors-and-their-role-in-guideline-devel.md",
      "narrative": null,
      "content": "25\nThe members of the GDG are not commissioned and do not receive any \nfinancial compensation other than for direct expenses associated with their \nwork on the guideline. The responsible technical officer may develop terms \nof reference so potential GDG members clearly understand their roles and \nresponsibilities before committing themselves. Members of the GDG participate in the guideline development process and at meetings as individuals \nand not as representatives of the institutions or organizations with which \nthey are affiliated.\nThe role of the GDG is to:\n■■\nprovide input into the scope",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Despite its heading, describes the development group's terms of participation and role: members are not paid beyond expenses and act as individuals rather than representatives of their institutions. Lists the group's roles, including giving input on scope, ranking outcomes, examining evidence profiles, interpreting benefits and harms, and formulating recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-052",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Composition of the guideline development group",
      "pageStart": 37,
      "pageEnd": 40,
      "target": "../sections/sec-052-321-composition-of-the-guideline-development-gro.md",
      "narrative": null,
      "content": "The GDG is multidisciplinary and composed of individuals from all WHO \nregions likely to use the guideline, except for employees of WHO or other \nUnited Nations organizations. Its membership should be balanced in terms \nof gender and geography. Possible conflict of interest is also an important \nconsideration when selecting and confirming GDG members (see Chapter 6). There are several ways to identify, nominate and select members of \nthe GDG. In addition to drawing members from established technical networks and WHO collaborating centres, consider publishing an open call for \nnominees. The aim",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how the development group should be composed: multidisciplinary, balanced by gender and geography, excluding WHO and UN staff, and screened for conflicts of interest. Describes member types and their value, including the chair and vice-chair or co-chairs, technical experts, end-users, representatives of affected people with the benefits of and barriers to service-user involvement, methods experts, an economist and an equity, human rights and gender expert.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-053",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The external review group",
      "pageStart": 40,
      "pageEnd": 41,
      "target": "../sections/sec-053-33-the-external-review-group.md",
      "narrative": null,
      "content": "The external review group is composed of persons interested in the subject of \nthe guideline as well as individuals who will be affected by the recommendations (often referred to as “stakeholders”). Thus, the external review group \nmay include technical experts, end-users, programme managers, advocacy \ngroups and individuals affected by the condition addressed in the guideline, \namong other stakeholders. This group is generally established by the steering group after the GDG is identified and once the guideline’s scope and \nChapter 3 \nContributors and their role in guideline development\n29\nkey",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the external review group of interested people and stakeholders, including experts, end-users, programme managers and affected individuals, and how and when the steering group establishes it. Says it should be balanced and may review the scope, key questions and the final guideline, where its role is to find errors, comment on clarity and implementation, and not to change recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-054",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The systematic review team",
      "pageStart": 41,
      "pageEnd": 45,
      "target": "../sections/sec-054-34-the-systematic-review-team.md",
      "narrative": null,
      "content": "Systematic reviews of the evidence are the basis for most types of recommendations (see Chapter 8). Because WHO staff usually lack the time to perform \nthese reviews, they normally commission them from external contractors. \nThese contractors should be identified very early in the guideline development process because they have expertise in the development of key questions and can help the steering group to establish a reasonable scope that \nconforms to the available budget and timeline.\nSystematic reviews can be commissioned from any group with the necessary expertise and no financial conflic",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that systematic reviews underpin most recommendations and are usually commissioned from external contractors with no financial conflicts, identified early, with the Cochrane and Campbell collaborations as possible sources. Then presents a multi-page table summarizing each contributing group, covering its responsibilities, functions, timing, establishment, leaders, expertise, size and whether declarations of interest are required, down to observers and funders.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-055",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Other individuals and groups involved in guideline development",
      "pageStart": 45,
      "pageEnd": 45,
      "target": "../sections/sec-055-35-other-individuals-and-groups-involved-in-guid.md",
      "narrative": null,
      "content": "development",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading page for the section on other individuals and groups involved in guideline development, with no body text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-056",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The guideline methodologist",
      "pageStart": 45,
      "pageEnd": 45,
      "target": "../sections/sec-056-351-the-guideline-methodologist.md",
      "narrative": null,
      "content": "At least one methodologist – an expert in guideline development processes \nand methods − should be involved in the development of WHO guidelines. \nThe methodologist complements the technical expertise of the subject matter \nexperts, programme managers and other members of the GDG. The guideline \nmethodologist is an expert in systematic reviews, GRADE, and the translation \nof evidence into recommendations. They generally have experience formulating public health recommendations. Methodologists should be identified early \nin the guideline process so that they can participate in planning, scoping",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that at least one methodologist, an expert in guideline processes, systematic reviews, GRADE and turning evidence into recommendations, should be involved. Says they should be identified early to help with planning and key questions and should help the development group formulate recommendations transparently at meetings.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-057",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Consultants with additional technical expertise",
      "pageStart": 45,
      "pageEnd": 45,
      "target": "../sections/sec-057-352-consultants-with-additional-technical-expert.md",
      "narrative": null,
      "content": "Additional commissioned experts are sometimes involved in the development of a guideline. These individuals have expertise in other essential areas, \nsuch as decision analysis (modelling), economics or epidemiology. They \nmay play a variety of roles in the guideline development process and may be \ninvited to attend and present at GDG meetings. They do not contribute to the \nformulation of recommendations, however, unless they are official members \nof the GDG, in which case they would not have a contract with WHO (see \nSection 3.2).",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes commissioned consultants with additional expertise such as modelling, economics or epidemiology, who may present at group meetings. States that they do not contribute to formulating recommendations unless they are official members of the development group.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-058",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Observers at the meeting of the guideline development group",
      "pageStart": 45,
      "pageEnd": 46,
      "target": "../sections/sec-058-353-observers-at-the-meeting-of-the-guideline-de.md",
      "narrative": null,
      "content": "group\nStakeholders such as nongovernmental organizations, advocacy groups, \nfunders, target audiences, and service-users may be invited to send a member \nor representative to GDG meetings. Their role is to observe, although the \nmeeting chair may ask them for information or an opinion. They do not \nparticipate in the formulation of recommendations.\n34",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that stakeholders such as nongovernmental organizations, advocacy groups, funders and service users may be invited to send observers to development group meetings. Observers do not take part in formulating recommendations, though the chair may ask for their information.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-059",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Designated writer/editor",
      "pageStart": 46,
      "pageEnd": 46,
      "target": "../sections/sec-059-354-designated-writereditor.md",
      "narrative": null,
      "content": "To ensure coherence, clarity and accuracy, one person should be respon-\nsible for drafting the guideline, incorporating comments from the GDG \nand peer review, and finalizing the document before publication. A clearly \nwritten guideline and a well-documented process are critical to the final \nclearance and usability of the guideline, so the writer needs to be involved \nin the planning and development stages, attend GDG meetings, and work \nclosely with the steering group and the GDG chair. The writer, who may be \na WHO staff member or can be commissioned, must be familiar with the \nWHO style gu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that one designated writer or editor should draft and finalize the guideline, incorporating group and peer-review comments. Says the writer should be involved from planning, attend meetings, know the WHO style guide and consult equity, human rights and gender experts on how people are described.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-060",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Funders of the guideline",
      "pageStart": 46,
      "pageEnd": 46,
      "target": "../sections/sec-060-36-funders-of-the-guideline.md",
      "narrative": null,
      "content": "The funder(s) of a guideline can play no role in the guideline development \nprocess and should not influence the recommendations. Private funders, \nincluding industry or foundations, may wish to observe GDG meetings, but \nthey must not contribute in any way to the systematic review and evidence \nappraisal process and, most particularly, to the formulation of recommen-\ndations. Governmental and intergovernmental agencies (e.g. the Centers \nfor Disease Control and Prevention [United States of America] or the Joint \nUnited Nations Programme on HIV/AIDS [UNAIDS]) may fund and/or \npartner in guidel",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that funders can play no role in development and must not influence recommendations. Private funders may observe meetings but not contribute to reviews or recommendations, while governmental and intergovernmental funders may partner, with their employees in the steering group but not the development group unless the dual role is declared and managed as a conflict of interest.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-061",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Identifying and managing conflicts of interest",
      "pageStart": 46,
      "pageEnd": 47,
      "target": "../sections/sec-061-37-identifying-and-managing-conflicts-of-interes.md",
      "narrative": null,
      "content": "Chapter 6 and the website of the Office of Compliance, Risk Management and \nEthics (8) explain the steps followed to identify, manage and report conflicts \nof interest involving GDG members and commissioned experts. Declara-\nChapter 3 \nContributors and their role in guideline development\n35\ntions of interests (DOI) are collected and reviewed before making appointments to the GDG. Any subsequent changes in GDG members’ declaration \nof interests must be reported to the steering group. Potential candidates for \nmembership who have major conflicts of interest, be they financial or nonfinancial, ca",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Points to Chapter 6 and the compliance office for how conflicts of interest are identified and managed, and says declarations are collected before appointments and later changes reported to the steering group. States that major conflicts bar appointment while minor ones can be managed individually or at group level. Also begins the section on managing an effective group meeting, with the steering group and chair responsible.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-062",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The role of the chair and vice-chair",
      "pageStart": 47,
      "pageEnd": 47,
      "target": "../sections/sec-062-381-the-role-of-the-chair-and-vice-chair.md",
      "narrative": null,
      "content": "During meetings, the chair must ensure that GDG members can present their \nviewpoints and that all relevant issues are discussed in a respectful and efficient \nmanner. In addition, the chair should keep the group focused on the agenda; \nreflect on and summarize the opinions of GDG members; raise issues that \ncould inform the decision process; and manage the group so as to achieve consensus. The chair and vice-chair should not impose their own opinions on the \ngroup, however they may put forth their views in a purely personal capacity.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the chair's duties at meetings: letting members present views, keeping to the agenda, summarizing opinions, raising relevant issues and steering the group to consensus. Says the chair and vice-chair should not impose their opinions, though they may state them in a personal capacity.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-063",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Decision-making in the guideline development group",
      "pageStart": 47,
      "pageEnd": 48,
      "target": "../sections/sec-063-382-decision-making-in-the-guideline-development.md",
      "narrative": null,
      "content": "The steering group must formulate a plan delineating how decisions will \nbe made by the GDG. This plan must be formulated and agreed upon by \nthe group’s chair and vice-chair before the first GDG meeting. It should \nbe presented to GDG members at the beginning of this first meeting, with \nthe opportunity for questions and discussion. GDGs sponsored by WHO \nshould generally make their recommendations through consensus, which \ncan be achieved by various means. Acceptable approaches for group decision-making must be defined and made explicit before any recommenda\n36\ntions are formulated, and a pl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the steering group must plan how the development group will make decisions, agreed with the chair and vice-chair before the first meeting and presented there. States that groups should generally decide by consensus, that acceptable approaches and a fallback if consensus fails must be defined in advance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-064",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Planning an effective meeting",
      "pageStart": 48,
      "pageEnd": 48,
      "target": "../sections/sec-064-39-planning-an-effective-meeting.md",
      "narrative": null,
      "content": "Most guidelines involve at least one face-to-face meeting of the GDG to formulate recommendations. Some groups hold an initial meeting to finalize a \nguideline’s scope and key questions (see Chapter 7). GDG meetings generally \ncover a lot of material and in them a number of important decisions are made \nwithin a short time. The steering group must ensure that all in attendance \nunderstand their role and the expected outputs of the meeting by providing \nGDG members with clear information about how the meeting will be run \nand about the tasks and roles of those present.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that most guidelines need at least one face-to-face meeting of the development group, sometimes preceded by one to settle scope and key questions. Says the steering group must make sure attendees understand how the meeting runs, their roles and the expected outputs.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-065",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Goals of the meeting",
      "pageStart": 48,
      "pageEnd": 48,
      "target": "../sections/sec-065-391-goals-of-the-meeting.md",
      "narrative": null,
      "content": "The steering group should consider the following questions when planning \na meeting of the GDG:\n■■\nWhat is the purpose of the meeting?\n■■\nWhat are the specific objectives for the meeting?\n■■\nWhat decisions do not require deliberation by the GDG (and can \ntherefore be made by the steering group)?\n■■\nWhat specific decisions and outputs are expected from the \nmeeting?",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists questions the steering group should consider when planning a meeting, covering its purpose, specific objectives, decisions that need not involve the group, and the decisions and outputs expected.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-066",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Preparing for the meeting",
      "pageStart": 48,
      "pageEnd": 49,
      "target": "../sections/sec-066-392-preparing-for-the-meeting.md",
      "narrative": null,
      "content": "■■\nHow are meeting participants expected to prepare before the meeting?\n■■\nWhat materials need to be sent to GDG members ahead of time and \nwhen should they be sent to allow adequate time for review?\n■■\nHave all DOI forms been collected and assessed and have appropriate \nmanagement plans been agreed upon with the director of the responsible technical officer’s technical unit?\nWHO handbook for guideline development\n37",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists questions on preparing for a meeting: how participants should prepare, what materials to send and when, and whether declaration of interest forms have been collected, assessed and given management plans.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-067",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Roles and process at the meeting",
      "pageStart": 49,
      "pageEnd": 49,
      "target": "../sections/sec-067-393-roles-and-process-at-the-meeting.md",
      "narrative": null,
      "content": "■■\nWhat roles are played by the steering group, GDG members, the methodologist, the systematic review team’s representative and observers?\n■■\nHow will declarations of interest and conflicts of interest be presented? \nWhat will be the level of detail? How will new disclosures be assessed \nand managed at the GDG meeting?\nIf the purpose of the GDG meeting is to finalize the scope and the key questions for guideline development:\n■■\nWho will draft the scope and key questions and how will these questions be identified?\n■■\nWill GDG members have the opportunity to review the questions \nbefore the meet",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists questions about roles and process at the meeting, such as the roles of each participant type, how conflicts of interest are presented and managed, and recording of deliberations. Gives separate question sets for meetings that finalize the scope and key questions and for meetings that develop recommendations, covering evidence summaries, evidence profiles, draft recommendations and templates.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-068",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Follow-up after the meeting",
      "pageStart": 49,
      "pageEnd": 50,
      "target": "../sections/sec-068-394-follow-up-after-the-meeting.md",
      "narrative": null,
      "content": "■■\nWhat follow-up will take place with meeting participants?\n■■\nIf recommendations are not finalized at the GDG meeting, how will \nthey be finalized after the meeting?\nChapter 3 \nContributors and their role in guideline development\n38",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists two questions on follow-up after the meeting: what follow-up occurs with participants, and how recommendations will be finalized if not completed at the meeting.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-069",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 50,
      "pageEnd": 51,
      "target": "../sections/sec-069-310-references.md",
      "narrative": null,
      "content": "1.\t\nWHO eManual /III - Human Resources/III.1 Duties, Obligations and Privileges/III.1.2 \nDeclaration of Interests [intranet site: available to WHO staff only]. Geneva: World Health \nOrganization; 2014 (http://emanual.who.int/p03/s01/Pages/DeclarationofInterests.aspx, \naccessed 27 November 2014).\n2.\t\nNational Institute for Health and Care Excellence (NICE) [website]. London: National \nInstitute for Health and Care Excellence; 2014 (http://www.nice.org.uk/, accessed 12 \nNovember 2014).\n3.\t\nNICE patient and public involvement policy. London: National Institute for Health and Care \nExcellence; 201",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A numbered reference list for Chapter 3, citing items such as WHO declaration-of-interests and compliance pages, NICE materials, the Cochrane and Campbell collaborations, the review committee site and the WHO style guide.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-070",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a guideline planning proposal?",
      "pageStart": 51,
      "pageEnd": 51,
      "target": "../sections/sec-070-41-what-is-a-guideline-planning-proposal.md",
      "narrative": null,
      "content": "A guideline planning proposal is a document that outlines the rationale and \nscope of a proposed guideline and the methods and resources involved in \ndeveloping it. The proposal includes many of the components of a protocol for \na systematic review and guideline, plus additional information on the groups \ncontributing to guideline development and the administrative steps required \nfor WHO guidelines. The responsible technical officer must submit a planning proposal to the GRC for each guideline to be developed and the GRC’s \napproval is required for guideline development to proceed to completi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a guideline planning proposal as a document outlining the rationale, scope, methods and resources of a proposed guideline, including protocol-like components plus information on contributing groups and administrative steps. States that the technical officer must submit one to the review committee for each guideline and that its approval is required for development to proceed to completion.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-071",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the purpose of the planning proposal?",
      "pageStart": 51,
      "pageEnd": 51,
      "target": "../sections/sec-071-42-what-is-the-purpose-of-the-planning-proposal.md",
      "narrative": null,
      "content": "To embark on any project or produce any document, including guidelines, \nits developers need an explicit, thoughtful and comprehensive plan or roadmap. The planning proposal serves several important purposes.\nFirst, a planning proposal helps to ensure that a high-quality and credible guideline is produced. The GRC and the Secretariat can provide constructive feedback, which helps to ensure that the final guideline will meet \nWHO standards. In addition, many steps in guideline development must \nbe performed correctly early in the process, since they cannot generally be \nremedied later, and a pl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains why a planning proposal is needed, giving reasons including securing early feedback on a credible guideline, setting its relationship to existing WHO guidelines, and avoiding overlap. Adds that it smooths the process by matching resources to scope, promotes accountability and protects integrity by fixing methods in advance and limiting bias.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-072",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Preparing the planning proposal",
      "pageStart": 51,
      "pageEnd": 52,
      "target": "../sections/sec-072-4-preparing-the-planning-proposal.md",
      "narrative": null,
      "content": "39\nThird, a carefully constructed planning proposal makes it more likely that \nthe guideline development process will be smooth and efficient. Resources \nwill closely match the proposed scope; relevant expertise will be identified \nand engaged early and throughout the development process; and potential difficulties, both procedural and technical, can be anticipated and planned for.\nFourth, the planning proposal promotes accountability. When the scope, \nmethods and timeline of the guideline are laid out and approved by the steering group a priori, each member of the steering group and the direc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the reasons for a planning proposal, saying it makes development smoother and more efficient, promotes accountability through an agreed scope, methods and timeline, and above all promotes the integrity of the process. States that deciding methods in advance reduces arbitrariness and bias and that mid-stream method changes driven by findings or dominant members must be avoided.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-073",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who develops the planning proposal?",
      "pageStart": 52,
      "pageEnd": 52,
      "target": "../sections/sec-073-43-who-develops-the-planning-proposal.md",
      "narrative": null,
      "content": "The responsible technical officer in the technical unit leading the guideline",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the responsible technical officer in the leading technical unit develops the planning proposal; the sentence continues onto the next page.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-074",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Preparing the planning proposal",
      "pageStart": 52,
      "pageEnd": 53,
      "target": "../sections/sec-074-45-preparing-the-planning-proposal.md",
      "narrative": null,
      "content": "close collaboration with other members of the steering group. Broad input \nmust be obtained, however, to ensure a useful product. The GDG, or at least \na subset of that group including the chair, should provide input into the \nguideline’s scope and key questions in PICO format. The systematic review \nteam and the guideline methodologist should also provide input into the key \nquestions before they are finalized. It may also be useful to have members of \nthe external review group provide input.\nIf resources allow, the GDG may meet in person before the planning \nproposal is finalized to define t",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the technical officer prepares the proposal in close collaboration with the steering group but must obtain broad input. Names the development group chair, the systematic review team, the methodologist and possibly the external review group as contributors to the key questions, and notes the group may meet in person, virtually or by email to define scope and methods.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-075",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "When should the planning proposal be developed and finalized?",
      "pageStart": 53,
      "pageEnd": 55,
      "target": "../sections/sec-075-44-when-should-the-planning-proposal-be-develope.md",
      "narrative": null,
      "content": "and finalized?\nThe planning proposal is the first major product of the guideline development process, and its preparation starts as soon as the technical unit decides \nto develop a guideline. The responsible technical officer should strive to \ndevelop and submit the proposal to the GRC for review as quickly as possible, but with sufficient consideration and preparation of the many elements \nin the proposal. The most difficult and time-consuming part of the planning \nproposal is formulating the key questions (in PICO format). These questions \nneed to be well developed in the planning proposal,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains the timing and preparation of the planning proposal, the first major product of development, starting when the unit decides to proceed and submitted once the key questions in the population, intervention, comparator and outcome format are complete. Describes submission to the review committee secretariat with a template and checklist after director approval, and presents a table of the essential proposal topics, from background and rationale to contributors, with responsible persons.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-076",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What if there are major changes in scope or approach after the GRC has approved the planning proposal?",
      "pageStart": 55,
      "pageEnd": 56,
      "target": "../sections/sec-076-46-what-if-there-are-major-changes-in-scope-or-a.md",
      "narrative": null,
      "content": "after the GRC has approved the planning proposal?\nIt is not unusual for changes to occur after the planning proposal is developed and approved by the GRC. New or unanticipated evidence, or new ideas \nfrom the steering group, the GDG or other interested parties, can engender \ndiscussions and the decision to change course. Such changes in planning \nproposals generally fall into one of the following categories:\n■■\nA major increase or decrease in scope ‒ Example: new key questions \nmight be added or, less commonly, questions might be removed.\n■■\nA change in the packaging of the guideline ‒ Example",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how to handle changes after the review committee approves the planning proposal, and lists the categories: major change in scope, change in packaging, major method change, change to a key question, and minor process changes. Says the first three kinds must be reviewed by the secretariat and sometimes the committee, while minor ones need not be, and the text includes the remainder of the proposal topics table covering writing, peer review, logistics, implementation and updating.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-077",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "For how long is an approved planning proposal in effect?",
      "pageStart": 56,
      "pageEnd": 56,
      "target": "../sections/sec-077-47-for-how-long-is-an-approved-planning-proposal.md",
      "narrative": null,
      "content": "effect?\nThe GRC approves planning proposals for a period of six months beyond \nthe publication date indicated in the planning proposal. If the final guideline is not submitted to the GRC before the end of the six-month period, the \nresponsible technical officer should discuss the delay with the GRC Secretariat. If the extended timeline may compromise the original methods and \nbibliographic database searches, a revised planning proposal may have to \nbe submitted to the GRC. Significant delays in the production of the final \nguideline should be discussed with the Secretariat.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the committee approves a planning proposal for six months beyond the planned publication date. Says delays beyond that should be discussed with the secretariat and that a revised proposal may be needed if the original methods and database searches could be compromised.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-078",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 56,
      "pageEnd": 57,
      "target": "../sections/sec-078-48-references.md",
      "narrative": null,
      "content": "1.\t\nGuidelines Review Committee (GRC) [intranet site: available to WHO staff only]. Geneva: \nWorld Health Organization; 2014 (http://intranet.who.int/homes/ker/grc/, accessed 14 \nNovember 2014).\n44",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list with one entry, the committee's intranet site.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-079",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Reflecting WHO’s values in its guidelines",
      "pageStart": 57,
      "pageEnd": 57,
      "target": "../sections/sec-079-51-reflecting-whos-values-in-its-guidelines.md",
      "narrative": null,
      "content": "The aim of all WHO’s work is to improve population health and decrease \nhealth inequities. Sustained improvements to physical, mental and social",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The opening sentences of Chapter 5, stating that WHO's work aims to improve population health and decrease health inequities; the text breaks off mid-sentence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-080",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Equity",
      "pageStart": 57,
      "pageEnd": 57,
      "target": "../sections/sec-080-521-equity.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-081",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Human rights",
      "pageStart": 57,
      "pageEnd": 57,
      "target": "../sections/sec-081-522-human-rights.md",
      "narrative": null,
      "content": "Attention to these areas enables WHO to more effectively deliver on its \ncommitments in its Twelfth General Programme of Work (1). This chapter \ndescribes how these important considerations can be integrated into each \nstep of the guideline development process and suggests eight entry points \nfor doing so.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Despite its heading, contains the end of the Chapter 5 introduction, saying that attention to these areas helps WHO deliver on its programme of work. States that the chapter describes how to integrate these considerations into each guideline development step through eight entry points.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-082",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Background",
      "pageStart": 57,
      "pageEnd": 59,
      "target": "../sections/sec-082-52-background.md",
      "narrative": null,
      "content": "The WHO Constitution (2) states that:\n“Health is a state of complete physical, mental and social well-being \nand not merely the absence of disease or infirmity.”\nand that\n“The enjoyment of the highest attainable standard of health is \none of the fundamental rights of every human being without \ndistinction of race, religion, political belief, economic or social \ncondition.” \nGuideline developers need to consider how their guidelines will contribute to the realization of the right to health, as we shall henceforth refer to the \nconcept embodied in the second of these statements. In so doing, the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the background to the chapter, quoting the WHO Constitution on health and the right to the highest attainable standard of health and saying developers should consider how guidelines advance that right. Defines equity as unfair and avoidable inequalities and discusses measuring them, and begins describing human rights dimensions of the right to health, including its freedoms and entitlements.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-083",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Gender",
      "pageStart": 59,
      "pageEnd": 59,
      "target": "../sections/sec-083-524-gender.md",
      "narrative": null,
      "content": "47",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A page containing only the number 47, under a heading for gender.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-084",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Social determinants of health and health inequities",
      "pageStart": 59,
      "pageEnd": 62,
      "target": "../sections/sec-084-523-social-determinants-of-health-and-health-ine.md",
      "narrative": null,
      "content": "The social determinants of health are the conditions in which people grow, \nlive, work and age (6). Health inequities are differences in health that are \nunfair, avoidable and remediable because they depend largely on the social \ndeterminants of health, which are amenable to improvement. WHO’s normative work, including guideline development, must thus take these determinants into consideration (7).\n5.2.4 Gender\n“Gender” refers to the roles, behaviours, activities and attributes that a given \nsociety considers appropriate for men and women and boys and girls. Thus, \ngender is socially construct",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines the social determinants of health and health inequities, and distinguishes gender from sex and describes how gender norms affect risk, access and outcomes. Explains how social determinants produce inequity and can be reduced through programmes and intersectoral action. Also reproduces a box of eight entry points for integrating equity, human rights and gender, from analysis of evidence on inequities to ensuring gender balance and accountability mechanisms in the guideline process.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-085",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Eight entry points for integrating equity, human rights, gender and the social determinants of health into WHO guidelines",
      "pageStart": 62,
      "pageEnd": 62,
      "target": "../sections/sec-085-53-eight-entry-points-for-integrating-equity-hum.md",
      "narrative": null,
      "content": "rights, gender and the social determinants of health \ninto WHO guidelines\nWHO’s normative work, including its recommendations and guidelines, \nmust integrate equity, human rights, gender and the social determinants of \nhealth. Eight entry points (Box 5.1) provide a practical approach for integrating these aspects into WHO guidelines. The relevance of specific strategies \nvaries across guideline topic areas, but all strategies should be systematically \nconsidered in the guideline development process.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says WHO's guidelines must integrate equity, human rights, gender and social determinants and introduces the eight entry points as a practical approach, to be systematically considered although relevance varies by topic.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-086",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Incorporating equity, human rights, gender and social determinants into each step in guideline development",
      "pageStart": 62,
      "pageEnd": 62,
      "target": "../sections/sec-086-54-incorporating-equity-human-rights-gender-and.md",
      "narrative": null,
      "content": "determinants into each step in guideline development\nEquity, human rights, gender and the social determinants of health must \nbe considered during all three phases of guideline development (Table 1.1) \n– planning, development, and publishing and updating – and during most \nsteps within each phase.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that equity, human rights, gender and social determinants must be considered in all three phases of guideline development (planning, development, and publishing and updating) and in most steps within each.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-087",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Phase 1: planning",
      "pageStart": 62,
      "pageEnd": 64,
      "target": "../sections/sec-087-541-phase-1-planning.md",
      "narrative": null,
      "content": "5.4.1.1 Request for guidance on a topic (Chapter 1)\nIn their request for guidance, Member States or other stakeholders might \nexplicitly ask that equity, human rights, gender and the social determinants \nof health be addressed during guideline development. Whether or not this \nrequest is made explicit, examining any health issue through the lens of \nequity, human rights, gender and the influence of social determinants is \nimportant. Doing so will help to better understand the needs and gaps to be \naddressed and may lead to interventions that are more effective in the longer \nterm and that will",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how to integrate equity, human rights, gender and social determinants into the planning phase. Covers the request for guidance, planning that aims to level up health across groups with stratifiers such as PROGRESS-Plus, composition of the contributing groups, and the planning proposal and scoping. Explains that the population, intervention, comparator and outcome elements of key questions should each take account of social position and the right to health.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-088",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Phase 2: development",
      "pageStart": 64,
      "pageEnd": 65,
      "target": "../sections/sec-088-542-phase-2-development.md",
      "narrative": null,
      "content": "5.4.2.1 Evidence retrieval and synthesis (Chapter 8)\nExisting systematic reviews seldom take equity, human rights, gender and \nsocial determinants into account, and a new review or an update of an existing review may be needed to analyse information about equity. Fortunately, \nthe volume of primary research in this field is increasing and the methods and tools for systematic reviews of evidence on equity and for combining qualitative and quantitative research findings are rapidly evolving. \nLooking beyond averages and disaggregating data sometimes calls for an \nadjustment of traditional data c",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how to integrate these considerations into the development phase. Covers evidence retrieval and synthesis, including equity-focused reviews and tools, assessment of evidence quality on subpopulations where data are sparse, and formulating recommendations, where likely equity gains may support strong recommendations and sparse equity evidence may support conditional ones with a research agenda and monitoring.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-089",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Phase 3: publishing and updating",
      "pageStart": 65,
      "pageEnd": 66,
      "target": "../sections/sec-089-543-phase-3-publishing-and-updating.md",
      "narrative": null,
      "content": "5.4.3.1 Producing and publishing the guideline (Chapter 12)\nThe final guideline and in its derivative products must convey clear messages with respect to equity, human rights, gender and social determinants. \nWHO handbook for guideline development\n54\nFor example, the process of developing a gender-sensitive guideline starts \nbefore the first words are put on paper and only ends when the last illustration has been chosen. Throughout the process careful attention should be \npaid to the use of language, the selection of case examples, the expressions \nused to refer to population groups, the choic",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes integration in the publishing and updating phase, saying the final guideline and derivative products must give clear messages on equity, human rights, gender and social determinants. Advises attention to language, examples, photographs and population descriptions from the start, and gender-sensitive, non-stigmatizing language in translations. The text ends at the heading for adaptation, implementation and evaluation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-090",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 66,
      "pageEnd": 69,
      "target": "../sections/sec-090-55-references.md",
      "narrative": null,
      "content": "determinants of health, gender equality and relevant international human \nrights standards and principles, should be included in the sections on implementation, monitoring and evaluation. The interventions recommended \nin a guideline pose the risk of increasing rather than reducing inequities, \ndepending on how they are implemented. For example, marginalized population groups might be ignored or strategies that make them the last to benefit might be used. Important gender differences might not be considered \nor unintended effects on certain subpopulations or population strata might \noccur. Suc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Completes the guidance on adaptation, implementation and evaluation, warning that implementation can increase inequities and that WHO staff must monitor effects on equity, human rights and gender. Then lists the Chapter 5 references and opens Chapter 6, which defines the basic concepts and principles of declaring and managing interests and how staff collect declarations and manage conflicts.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-091",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a conflict of interest?",
      "pageStart": 69,
      "pageEnd": 70,
      "target": "../sections/sec-091-61-what-is-a-conflict-of-interest.md",
      "narrative": null,
      "content": "A conflict of interest is an important potential source of bias and diminished \ncredibility in the development of WHO guidelines. “A conflict of interest is a \nset of circumstances that creates a risk that professional judgment or actions \nregarding a primary interest will be unduly influenced by a secondary interest” (1). The Declaration of Interests form at WHO (2) contains a similar \ndefinition: [A conflict of interest is] “any interest declared by an expert that \nmay affect or reasonably be perceived to affect the expert’s objectivity and \nindependence in providing advice to WHO.”\nAs noted",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a conflict of interest as a set of circumstances creating a risk that professional judgment about a primary interest is unduly influenced by a secondary interest, and gives WHO's declaration-form wording. Explains the terms primary interest, secondary interest and undue influence, and argues that a conflict exists whether or not it affects decisions, so phrases such as potential or perceived conflict should be avoided.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-092",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What types of conflicts of interest exist?",
      "pageStart": 70,
      "pageEnd": 71,
      "target": "../sections/sec-092-62-what-types-of-conflicts-of-interest-exist.md",
      "narrative": null,
      "content": "Conflicts of interest are of two basic types: financial and nonfinancial. Both \nare relevant to guideline development. Financial interests can be directly \nmeasured in monetary units, such as for stocks or patents owned, money \nreceived for commissioned work, or an honorarium for a speaking engagement. Nonfinancial interests, on the other hand, cannot readily be measured \nin monetary units and are less tangible and thus more difficult to identify, \nmeasure and manage. They include any interest that could be reasonably \nperceived to affect an individual’s objectivity and independence while work",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Distinguishes financial conflicts, which can be measured in money such as stocks, patents, commissioned work or honoraria, from nonfinancial ones, which are harder to identify and include professional advancement, prestige or drive to publish. Notes that intellectual conflicts of interest are one nonfinancial type.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-093",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Declaration and management of interests",
      "pageStart": 71,
      "pageEnd": 71,
      "target": "../sections/sec-093-6-declaration-and-management-of-interests.md",
      "narrative": null,
      "content": "59\nThe declaration of one or more secondary interests (declaration of \ninterests) does not automatically mean that a conflict of interest is present: there is a distinction between the two. A transparent and objective \nprocess for assessing a declaration of interests is required to determine if a \nconflict exists and what its effects might be, and to manage any significant \nconflict of interest. This chapter describes the processes and procedures \nfor identifying and managing conflicts of interest during guideline development at WHO.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that declaring an interest does not automatically mean a conflict exists, and that a transparent and objective assessment is needed to decide whether one exists and manage it. Introduces the processes for identifying and managing conflicts during WHO guideline development.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-094",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Why is a conflict of interest important in guideline development at WHO?",
      "pageStart": 71,
      "pageEnd": 71,
      "target": "../sections/sec-094-63-why-is-a-conflict-of-interest-important-in-gu.md",
      "narrative": null,
      "content": "development at WHO?\nCertain data point to an association between the secondary interests of \nauthors and funders and study outcomes (4), and between conflicts of interest and the conclusions drawn from systematic reviews (5). Data on the effects \nof industry relationships and the intellectual interests of guideline sponsors \nand authors are confined to case studies (6). Conflicts of interest can introduce bias into almost every step of the guideline development process, from \nscoping and the development of key questions, to the formulation and presentation of recommendations. In addition, conf",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains why conflicts matter, citing associations between secondary interests and study outcomes and conclusions, with evidence on guideline sponsors limited to case studies. States that conflicts can bias almost every step and undermine credibility of recommendations, guidelines and WHO, so developers must handle them in a proactive, transparent and defensible manner.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-095",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What are WHO’s policies on conflicts of interest?",
      "pageStart": 71,
      "pageEnd": 72,
      "target": "../sections/sec-095-64-what-are-whos-policies-on-conflicts-of-intere.md",
      "narrative": null,
      "content": "Guideline developers at WHO must be familiar with WHO’s policies on \nobtaining declarations of interests and assessing and managing conflicts of \ninterest. An overview of the process for identifying, managing and reporting such conflicts during guideline development at WHO is presented in \nBox 6.1, with further details provided below. Various websites provide additional information about WHO policies and procedures related to conflicts \nof interest and guideline development (2, 7, 8). Additional information can \nbe obtained from the Office of Compliance, Risk Management and Ethics.\n60\nWHO hand",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says guideline developers must know WHO's policies on obtaining declarations of interests and assessing and managing conflicts, points to an overview box and further web resources, and names the compliance, risk management and ethics office as a source of information.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-096",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who should complete a declaration of interests form?",
      "pageStart": 72,
      "pageEnd": 75,
      "target": "../sections/sec-096-65-who-should-complete-a-declaration-of-interest.md",
      "narrative": null,
      "content": "According to WHO rules and regulations, a declaration of interests form and an \nanalysis of all declarations must be performed whenever an individual provides \nindependent advice to WHO (7) − that is, whenever an expert is asked to serve \nin an advisory role in a personal capacity. In guideline development, this means \nthat anyone invited to participate in the development of a WHO guideline must \ncomplete the declaration of interests form and agree to the publication of a \nsummary of that declaration in the guideline (see Table 6.1 and Fig. 6.1). This \nincludes all members of the GDG, individu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains who must complete a declaration of interests form: anyone providing independent advice in a personal capacity, including development group members, systematic reviewers, methodologists and the writer, who must also agree to publication of a summary. States that observers representing organizations need not complete one but their affiliations must be transparent. Presents a five-step overview of identifying, managing and reporting interests and a table of declaration and management by group, plus a figure of the assessment flow whose content is only yes and no labels.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-097",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What interests need to be disclosed?",
      "pageStart": 75,
      "pageEnd": 76,
      "target": "../sections/sec-097-66-what-interests-need-to-be-disclosed.md",
      "narrative": null,
      "content": "Relevant financial as well as nonfinancial interests should be disclosed and \nsubsequently assessed and managed in order to minimize bias in guideline \ndevelopment and to ensure credible recommendations. A financial conflict of \ninterest arises when an individual or organization receives income or mon-\netary support that is related to, or could be affected by, the outcome of the \nWHO meeting or activity in which they are involved. This includes both per-\nsonal financial interests and the interests of the individual’s immediate family \nmembers (defined as the spouse, or partner with whom one ha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines financial and nonfinancial interests that must be disclosed in guideline development and explains why they are assessed and managed. It lists examples of financial interests, such as paid work, research support, patents, grants and shares, notes the US$ 5000 reporting threshold (US$ 1000 for non-monetary research support), and gives examples of nonfinancial interests like prior publications, public positions and affiliations with advocacy organizations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-098",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Collecting declarations of interests",
      "pageStart": 76,
      "pageEnd": 76,
      "target": "../sections/sec-098-67-collecting-declarations-of-interests.md",
      "narrative": null,
      "content": "Declarations of interests are collected using the standard WHO form for \nexperts. Such a form should be completed, signed by the expert or potential \ncontractor, and reviewed and assessed before firm invitations to participate in \na guideline development process are issued or contracts are signed. External \nexperts and contractors should be instructed to notify the responsible tech-\nnical officer of any change in relevant interests, and declaration of interests \nforms should be updated on a regular basis. Declaration of interests forms \nare confidential documents that should be securely stored",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how declarations of interests are collected using the standard WHO form, which must be completed, signed and assessed before invitations or contracts are issued. It adds that experts must report changes, that forms are confidential and securely stored, and that a curriculum vitae is requested alongside the form.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-099",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Assessing declarations of interests",
      "pageStart": 76,
      "pageEnd": 79,
      "target": "../sections/sec-099-68-assessing-declarations-of-interests.md",
      "narrative": null,
      "content": "Little is known about the effect of declarations and conflicts of interest on \nsomeone’s behaviour, how group participants and GDG members and chairs \nweigh or discount information or opinions presented by conflicted individu-\nals, and how guideline end-users interpret information on conflicts of inter-\nest. The following guidance is based on: the scant existing evidence; standard \nand best practices among leading guideline development groups interna-\ntionally; sound legal and ethical principles; and expert opinion. In practical \nterms, three basic steps are involved in assessing declarations",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the three steps for assessing declarations of interest: staff review of the form with the expert's CV, a decision on whether a conflict of interest actually exists, and a judgement of how severe it is. It notes how little evidence exists on the effects of conflicts and that the guidance rests on best practice and expert opinion. It includes Table 6.2, with principles for collecting, assessing and managing declarations (report all funders, no private sector role, avoid and minimize conflicts, no financial conflicts for chairs), and Table 6.3, with criteria for judging severity such as the value and scope of the interest, the individual's discretion and the possible harm.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-100",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Managing conflicts of interest at the individual level",
      "pageStart": 79,
      "pageEnd": 79,
      "target": "../sections/sec-100-69-managing-conflicts-of-interest-at-the-individ.md",
      "narrative": null,
      "content": "All declarations of interests should be reviewed and assessed by the respon-\nsible technical officer in consultation with the director of the technical \nunit. These individuals must decide whether a conflict of interest is severe \nenough to require a management strategy. In other words, they must decide \nto what extent the individual can participate in development of the guide-\nline. Decisions are made on a case-by-case basis depending on the severity \nof the conflict of interest. Merely disclosing the conflict does not constitute \nan adequate management strategy: careful consideration must be",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that each declaration is reviewed by the responsible technical officer with the director of the technical unit, who decide case by case whether a conflict needs a management strategy. It stresses that disclosure alone is not adequate management.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-101",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guideline development group members",
      "pageStart": 79,
      "pageEnd": 81,
      "target": "../sections/sec-101-691-guideline-development-group-members.md",
      "narrative": null,
      "content": "At the level of the individual potential GDG member, management options \nrepresent a spectrum that includes:\n■■\nNo action ‒ the conflict of interest requires no action beyond \ndeclaration at the GDG meeting and reporting in the published \nguideline.\n68\nWHO handbook for guideline development\n■■\nParticipation is restricted ‒ the individual is excluded from parts of \nmeetings and of the guideline development process.\n––\nThe conflicted individual can be excluded from the formulation of specific recommendations but allowed to participate in all \ndiscussions.\n––\nThe conflicted individual can be barr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the options for managing a guideline development group member's conflict of interest, from no action, through restricted participation, to full exclusion. It lists conflicts that preclude participation, such as holding over US$ 5000 in shares or a patent on a product under consideration, and situations where participation should be limited, such as recent industry employment or authorship of key studies. It also states that no evidence supports a particular monetary threshold, so processes must be explicit, transparent and defensible.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-102",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Peer reviewers",
      "pageStart": 81,
      "pageEnd": 82,
      "target": "../sections/sec-102-692-peer-reviewers.md",
      "narrative": null,
      "content": "Declarations of interests should be collected from all peer reviewers. When \nreviewers are affiliated with organizations that clearly have a vested interest in the outcome of specific recommendations, a declaration of interests is \nnot usually required; reporting the reviewer’s affiliation or institution in the \nguideline is considered sufficient disclosure.\nThe external review group, including peer reviewers, may have significant conflicts of interest. In fact, these individuals may have been selected \n70\nWHO handbook for guideline development\nbecause of their perspectives and secondary inter",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that declarations of interests are collected from all peer reviewers, although reviewers whose organizations clearly have a vested interest need only report their affiliation. It notes that reviewers with conflicts can still help anticipate controversy, but their declarations must be transparent and their comments assessed case by case.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-103",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Managing conflicts of interest at the group level",
      "pageStart": 82,
      "pageEnd": 82,
      "target": "../sections/sec-103-610-managing-conflicts-of-interest-at-the-group.md",
      "narrative": null,
      "content": "While financial conflicts of interest are usually managed at the individual \nlevel, nonfinancial conflicts of interest (including intellectual ones) may be \nmanaged at both the individual and group level. Group composition is influential in any decision-making process and observational evidence shows a \ncorrelation between the composition of GDGs and specific recommendations. For example, physicians tend to recommend procedures that they \npersonally deliver, whereas multidisciplinary groups tend to be more conservative in their recommendations (11, 12). If individuals with a particular \nviewpo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that nonfinancial conflicts, including intellectual ones, may be managed at the group as well as the individual level because group composition influences recommendations. It cites evidence that physicians favour procedures they deliver and warns of committee stacking.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-104",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Minimizing the risk posed by conflicts of interest when constituting guideline development groups",
      "pageStart": 82,
      "pageEnd": 84,
      "target": "../sections/sec-104-6101-minimizing-the-risk-posed-by-conflicts-of-i.md",
      "narrative": null,
      "content": "constituting guideline development groups\nThere is scant evidence upon which to base recommendations on the optimal composition of GDGs to minimize the risk that intellectual conflicts of \ninterest will bias their decisions. The following suggestions are based largely \nChapter 6 \nDeclaration and management of interests\n71\non expert opinion and standards recommended by other organizations (1). \n(See also the guidance in Chapter 3.)\n■■\nGDG chair, co-chairs and vice-chair\n––\nThe chair, co-chair or vice-chair of a GDG should not have any \nfinancial conflicts of interest.\n––\nIf the co-chairs or the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives suggestions for constituting guideline development groups to limit the risk of intellectual conflicts. It covers chairs without financial conflicts (possibly a methodologist), a majority of members with no conflicts, balancing perspectives, separating the GDG from the evidence review and writing tasks, commissioning methodologists, and including varied stakeholders.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-105",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Minimizing the risk posed by conflicts of interest during the guideline development process",
      "pageStart": 84,
      "pageEnd": 86,
      "target": "../sections/sec-105-6102-minimizing-the-risk-posed-by-conflicts-of-i.md",
      "narrative": null,
      "content": "guideline development process\nAppropriate management of disclosures and conflicts of interest does not \nend with the assessment of the declarations and the formulation of a plan for \nthe management of conflicts. The responsible technical officer and the steering group have additional and continuous responsibilities.\n■■\nAlthough GDG members participate in guideline development at \nWHO in an individual capacity, they must all provide their institutional affiliations, along with the goals and purpose of their institutions at the beginning of each GDG meeting.\n■■\nThe declarations of interests made",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes ongoing responsibilities for managing conflicts during guideline development, including declaring institutional affiliations and presenting and updating declarations at each meeting. It then explains how declarations must be reported in the guideline (tabular or narrative, required for GRC approval), gives three worked examples of such reports, and states that forms are kept confidential for at least 10 years.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-106",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What sources of funding are appropriate for WHO guidelines?",
      "pageStart": 86,
      "pageEnd": 86,
      "target": "../sections/sec-106-612-what-sources-of-funding-are-appropriate-for.md",
      "narrative": null,
      "content": "guidelines?\nWHO guidelines cannot be funded, in whole or in part, by private sector \nentities or by non-state actors that are not at “arm’s length” of a private sector \nentity (2). Private sector entities are commercial enterprises. That is to say, \nthey are businesses that are intended to make a profit for their owners. The \nterm also refers to entities that represent private sector entities, or are governed or controlled by private entities. This includes (but is not limited to) \nbusiness associations representing commercial enterprises; entities not at an \narm’s length of their commercial s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that WHO guidelines cannot be funded wholly or partly by private sector entities or non-state actors not at arm's length from them, and explains what counts as a private sector entity. It directs staff to make reasonable efforts to learn a funder's revenue sources and to consult the Office of Compliance, Risk Management and Ethics with questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-107",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 86,
      "pageEnd": 89,
      "target": "../sections/sec-107-613-references.md",
      "narrative": null,
      "content": "1.\t\nGraham RMM, Wolman DM, Greenfield S, Steinberg E, editors. Clinical practice guidelines \nwe can trust. Washington (DC): The National Academies Press; 2011 (http://www.nap.edu/\nopenbook.php?record_id=13058, accessed 11 November 2014).\n2.\t\nDeclaration of Interests (WHO Experts) [intranet site: available to WHO staff only]. Geneva: \nWorld Health Organization; 2014 (http://intranet.who.int/homes/cre/ethics/doiexperts/, \naccessed 11 November 2014).\n3.\t\nGuyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of \nguidelines and conflict of interest: a potential sol",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list for the chapter on declaration and management of interests, citing books, journal articles on conflict of interest and industry sponsorship, and WHO intranet documents.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-108",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Types of questions",
      "pageStart": 89,
      "pageEnd": 89,
      "target": "../sections/sec-108-71-types-of-questions.md",
      "narrative": null,
      "content": "There are two basic types of questions: background and foreground questions. Background questions provide context and rationale for the guideline; \nforeground questions directly inform and underpin recommendations.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the two basic types of questions, background and foreground, stating that background questions give context and rationale while foreground questions directly inform recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-109",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Background questions",
      "pageStart": 89,
      "pageEnd": 90,
      "target": "../sections/sec-109-711-background-questions.md",
      "narrative": null,
      "content": "These questions pertain to important background information on the issues \nunder consideration and their context. They do not relate to evidence of the \ntype that directly informs recommendations, but they do lead to information \nwhich helps to frame and formulate the foreground questions. Background \nquestions may pertain, for instance, to definitions; the prevalence, burden \nand distribution of the problem or disease at hand; or the pathophysiologic \nmechanisms underlying the effects of exposures or potential interventions. \nHere are some examples:\n■■\nWhat are the potential mechanisms by whi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines background questions as those that supply context, such as definitions, disease prevalence and burden, or underlying mechanisms, and help frame the foreground questions. It gives examples, explains that they can usually be answered from a single cited valid source rather than a systematic review, and notes the exception where a prevalence question is central and becomes a foreground question.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-110",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Foreground or key questions",
      "pageStart": 90,
      "pageEnd": 90,
      "target": "../sections/sec-110-712-foreground-or-key-questions.md",
      "narrative": null,
      "content": "These questions form the basis of the search for the evidence that will underpin the recommendations. They will be of various types, depending on the \nnature of the guideline and the specific topics it will cover. When a potential \nrecommendation focuses on an intervention, the key questions pertain to \nthe efficacy, effectiveness and potential harms of the intervention, as well as \nto factors such as acceptability, feasibility, cost and cost–effectiveness, and to \nthe values and preferences of the people who will be affected by the recommendations. When the topic focuses on a diagnostic test,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes foreground or key questions as the basis of the evidence search behind recommendations, and explains how their focus varies by topic: efficacy, harms, acceptability, feasibility and cost for interventions; sensitivity and specificity for diagnostic tests; and baseline risk or relative risk for exposures. It illustrates each with example questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-111",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Population",
      "pageStart": 90,
      "pageEnd": 91,
      "target": "../sections/sec-111-721-population.md",
      "narrative": null,
      "content": "Chapter 7",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A near-empty fragment containing only the words Chapter 7.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-112",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Formulating questions and selecting outcomes",
      "pageStart": 91,
      "pageEnd": 91,
      "target": "../sections/sec-112-7-formulating-questions-and-selecting-outcomes.md",
      "narrative": null,
      "content": "79\n■■\nIn multi-drug-resistant tuberculosis patients, does the addition \nof bedaquiline to WHO-recommended second-line drug therapy \nimprove outcomes, as reflected by culture conversion and the time to \nsuch conversion?\nForeground questions are the most important ones for guideline development. The evidence identified on these questions will be used by the GDG \nto underpin the recommendations and these questions usually require a systematic review and assessment of the quality of the evidence for selected outcomes using the GRADE approach (see Chapter 9) (1). Foreground questions \nshould theref",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Extraction put text under the wrong heading: this section ends the examples of foreground questions with a bedaquiline example for multi-drug-resistant tuberculosis. It then states that foreground questions are the most important for guideline development, usually need a systematic review with GRADE quality assessment, and should be framed in PICO format.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-113",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Formulating key questions in PICO format",
      "pageStart": 91,
      "pageEnd": 91,
      "target": "../sections/sec-113-72-formulating-key-questions-in-pico-format.md",
      "narrative": null,
      "content": "PICO is an acronym for population, intervention (or exposure), comparator and outcome − four elements that should be considered in any question \ngoverning a systematic search of the evidence. Sometimes T is added for the \ntiming of the measurement of outcomes or for the duration of the intervention \nor exposure, and S for the setting where the recommendations will be implemented (PICOTS). For simplicity we use PICO in this handbook, wrapping",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines PICO as population, intervention or exposure, comparator and outcome, and mentions the PICOTS variant adding timing and setting. The text breaks off mid-sentence at the end of the section.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-114",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Intervention or exposure",
      "pageStart": 91,
      "pageEnd": 93,
      "target": "../sections/sec-114-722-intervention-or-exposure.md",
      "narrative": null,
      "content": "the P (population) or the I. The PICO format also provides a useful structure \nfor delineating inclusion and exclusion criteria for the body of evidence (see \nChapter 8) and for formulating recommendations (see Chapter 10).\n7.2.1 Population\nWhat group or population is targeted by the intervention or exposure \nunder consideration?\n■■\nHow can the members of the target population be most accurately \ndescribed? What are the relevant demographic characteristics? Consider age, sex and other social, geographic and environmental characteristics that are of relevance to the guideline topic.\n■■\nWhat is",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Extraction put text under a heading that covers only part of it: it finishes the PICO introduction by noting that PICO also structures inclusion criteria and recommendations. It then lists guiding questions for the population element (demographics, setting, subpopulations) and for the intervention or exposure element (what treatment, policy or determinant is evaluated and at what levels).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-115",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Outcomes",
      "pageStart": 93,
      "pageEnd": 93,
      "target": "../sections/sec-115-724-outcomes.md",
      "narrative": null,
      "content": "81",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A page number only, the number 81.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-116",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Comparator",
      "pageStart": 93,
      "pageEnd": 94,
      "target": "../sections/sec-116-723-comparator.md",
      "narrative": null,
      "content": "What courses of action or exposures stand as alternatives with which to \ncompare those recommended in the guideline?\n■■\nThe comparator in a recommendation may be standard practice – \nincluding no specific treatment – or another intervention relevant to \ncurrent practice or policy.\n■■\nComparators may be placebo, no intervention, the standard of \ncare, a gold or reference standard diagnostic test, variations of the \nintervention under consideration (such as different dosages), a different level of exposure or intervention, or a completely different \nintervention.\n■■\nComparisons may also be estab",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists guiding questions for the comparator element of PICO, covering alternatives such as standard practice, placebo, no intervention and other interventions, and stresses that comparators close to current practice are most useful. It also begins the outcomes element, asking which benefits, harms and equity effects matter most to affected people and calling for input from experts, programme managers and those affected.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-117",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Examples of key questions in PICO format",
      "pageStart": 94,
      "pageEnd": 95,
      "target": "../sections/sec-117-725-examples-of-key-questions-in-pico-format.md",
      "narrative": null,
      "content": "The following are well-formulated key questions:\n■■\nIn a rural population in a low-income country (Population), does \npaying higher salaries to health workers (Intervention), compared with \npaying standard salaries (Comparator), increase the number of health \nworkers in rural areas (Outcome) within a 5-year period?\n■■\nIn babies born to HIV-positive women (P), does screening with a new \nrapid diagnostic test (I), compared with standard diagnostic methods (C), accurately detect disease (O) by 12 months of age?\n■■\nIn an urban population (P), is exposure to an environmental chemical (I), compared",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents six well-formulated key questions in PICO format, with the population, intervention, comparator and outcome labelled in each. It then contrasts one poorly formulated question about a drug for multi-drug-resistant tuberculosis, lists what it leaves unspecified, and gives a better rewording.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-118",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Types of key questions",
      "pageStart": 95,
      "pageEnd": 98,
      "target": "../sections/sec-118-73-types-of-key-questions.md",
      "narrative": null,
      "content": "Although the PICO framework was originally devised to address the efficacy, \neffectiveness and potential harms of an intervention, it can be applied to \nother types of questions, as outlined in Table 7.1. The general types of questions most relevant to WHO guidelines relate to the following:\n■■\nintervention efficacy and effectiveness;\n■■\nintervention harms;\n■■\ndiagnostic approaches and test characteristics;\n■■\nthe values and preferences of the individuals affected by an intervention;\n■■\nrisk assessment, including baseline risk (prognosis), and additional risk \nfrom a given exposure; and\nWHO ha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that PICO can be applied beyond intervention efficacy to the main question types relevant to WHO guidelines: efficacy and effectiveness, harms, diagnosis, values and preferences, and risk assessment. It introduces Table 7.1, which gives the syntax and an example for each type.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-119",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Broadly- versus narrowly-focused key questions",
      "pageStart": 98,
      "pageEnd": 99,
      "target": "../sections/sec-119-74-broadly--versus-narrowly-focused-key-question.md",
      "narrative": null,
      "content": "Questions based on the PICO format may be broad or narrow in scope. A \nbroad question will lead to a comprehensive summary of a larger body of evidence and more generalizable findings, but it may also require significantly \nmore resources to answer. A broad question may also yield very heterogeneous evidence, making interpretation difficult. On the other hand, a narrow \nquestion may be easier to manage, but the evidence might be sparse and the \nfindings less generalizable. Depending on the scope of the guideline and the \navailability of information, the steering group may decide to split a bro",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Compares broad and narrow PICO questions, noting that broad ones give generalizable but resource-heavy and heterogeneous evidence while narrow ones are manageable but sparser, with the steering group able to split broad questions. It gives paired examples and shows, with a type 2 diabetes screening example, how several key questions can inform one recommendation question.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-120",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Number of key questions",
      "pageStart": 99,
      "pageEnd": 99,
      "target": "../sections/sec-120-75-number-of-key-questions.md",
      "narrative": null,
      "content": "The number of key questions for a guideline varies greatly, depending on the \nscope of the guideline (the number of areas of uncertainty) and the available \nresources and timeline. In addition, key questions vary greatly in scope and \ncomplexity for each component of PICO. As noted above, for some types \nof recommendations, several key questions are needed to provide the evidence base; for others, only one key question and one systematic review are \nrequired. There is no point in wrapping several key questions into one: the \nworkload and resources required remain the same.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the number of key questions depends on guideline scope, resources and timeline, and that some recommendations need several key questions while others need one. It advises against combining several key questions into one because the workload stays the same.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-121",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Selecting and rating outcomes",
      "pageStart": 99,
      "pageEnd": 101,
      "target": "../sections/sec-121-76-selecting-and-rating-outcomes.md",
      "narrative": null,
      "content": "The purpose of any recommendation is to achieve a net benefit. Thus, selecting the most important outcomes is critical to producing a useful guideline. \nThe value attached to a given outcome by different populations and subpopulations varies. For this reason, it is essential to ask members of the GDG \n− which should contain end-users, implementers, patient representatives, \npolicy-makers, technical experts and perhaps also other stakeholders – to \nidentify the key outcomes that need to be considered in a guideline.\nThe steering group should compose an initial list of relevant outcomes, \ninclud",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how to select and rate outcomes: the steering group drafts a list of desirable, undesirable and equity-related outcomes, the GDG adds to it, and members rate each on a 1 to 9 scale (7 to 9 critical, 4 to 6 important, 1 to 3 unimportant) from the perspective of those affected. It describes using the mean or median score, in-person discussion or a Delphi approach, and limiting the list to about seven important or critical outcomes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-122",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Finalizing the key questions and priority outcomes",
      "pageStart": 101,
      "pageEnd": 101,
      "target": "../sections/sec-122-77-finalizing-the-key-questions-and-priority-out.md",
      "narrative": null,
      "content": "Key questions should be finalized by the steering group after receiving input \nfrom all the relevant experts, including end-users (e.g. programme managers, partner agencies, and consumer and patient groups). Because the number \nof questions that call for systematic reviews will be a major determinant of \nthe time and resources needed to complete the guideline, the steering group \nshould aim to restrict the questions to those dealing with the areas of greatest controversy and uncertainty. This will help to ensure a comprehensive \nand useful guideline. The following steps should be followed to d",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the steering group finalizes the key questions after input from experts and end-users, restricting systematic-review questions to areas of greatest controversy and uncertainty because they drive time and resources. It introduces the stepwise process shown in Figure 7.2.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-123",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 1: generate an initial list of questions",
      "pageStart": 101,
      "pageEnd": 101,
      "target": "../sections/sec-123-step-1-generate-an-initial-list-of-questions.md",
      "narrative": null,
      "content": "The steering group develops an initial list of potential questions based on the \nagreed-upon scope of the guideline. These are then divided into background \nand foreground questions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 1 of finalizing key questions: the steering group drafts an initial list of questions from the agreed scope and divides them into background and foreground questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-124",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 2: draft the key questions in PICO format",
      "pageStart": 101,
      "pageEnd": 101,
      "target": "../sections/sec-124-step-2-draft-the-key-questions-in-pico-format.md",
      "narrative": null,
      "content": "The steering group, with input from the GDG, the systematic review team \nand the guideline methodologist, applies the PICO framework to the foreground questions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 2: the steering group, with input from the GDG, the systematic review team and the methodologist, writes the foreground questions in PICO format.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-125",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 3: list relevant outcomes",
      "pageStart": 101,
      "pageEnd": 101,
      "target": "../sections/sec-125-step-3-list-relevant-outcomes.md",
      "narrative": null,
      "content": "The steering group should list relevant outcomes, including both the potential benefits and harms of the intervention or exposure. The GDG then \nreviews this list and may add additional outcomes considered important.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 3: the steering group lists relevant benefits and harms as outcomes, and the GDG reviews the list and may add important ones.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-126",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 4: review and revise",
      "pageStart": 101,
      "pageEnd": 103,
      "target": "../sections/sec-126-step-4-review-and-revise.md",
      "narrative": null,
      "content": "The list of questions and outcomes of interest should be sent by the steering \ngroup to the GDG and possibly to other stakeholders for review and comment.\nWHO handbook for guideline development\n90\nFig. 7.2.\t\nPrioritizing key questions and outcomes\nGenerate an initial list of \nquestions, both background \nand foreground\nDraft the key (foreground) \nquestions in PICO format\n(require a systematic review)\nList all relevant outcomes\nReview  and revise the draft key \nquestions and outcomes\nWhat is missing?\nPrioritize the key questions\nRate the outcomes for the  \nhigh priority key questions \nas critica",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 4, in which the draft questions and outcomes are sent to the GDG and possibly other stakeholders for review and comment. The extracted text also contains the text of Figure 7.2, a flowchart of prioritizing key questions and outcomes for both foreground and background questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-127",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 5: prioritize the key questions",
      "pageStart": 103,
      "pageEnd": 103,
      "target": "../sections/sec-127-step-5-prioritize-the-key-questions.md",
      "narrative": null,
      "content": "The steering group, with input from the GDG, the systematic review team \nand the methodologist, finalizes the list of background and foreground questions and ranks them in order of priority. Determining which foreground \nquestions need systematic reviews follows next.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 5: the steering group, with input from the GDG, review team and methodologist, finalizes and ranks the background and foreground questions, after which it decides which foreground questions need systematic reviews.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-128",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 6: rate the outcomes",
      "pageStart": 103,
      "pageEnd": 103,
      "target": "../sections/sec-128-step-6-rate-the-outcomes.md",
      "narrative": null,
      "content": "The GDG and/or other stakeholders, such as service users and others directly \naffected by the recommendations, then rate or rank the listed outcomes using \na formal process, such as that described above.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 6: the GDG and other stakeholders, including those directly affected, rate or rank the listed outcomes using a formal process.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-129",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 7: finalize the key questions and the important and critical outcomes",
      "pageStart": 103,
      "pageEnd": 103,
      "target": "../sections/sec-129-step-7-finalize-the-key-questions-and-the-import.md",
      "narrative": null,
      "content": "outcomes\nThe steering group should list the high-priority key questions and the outcomes which the GDG will use to formulate recommendations.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 7: the steering group lists the high-priority key questions and the outcomes the GDG will use to formulate recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-130",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Analytic frameworks",
      "pageStart": 103,
      "pageEnd": 104,
      "target": "../sections/sec-130-78-analytic-frameworks.md",
      "narrative": null,
      "content": "A diagram illustrating the components of the intervention or exposure, and \nits relationship to the population, comparator and outcomes, is an extremely \nuseful tool for the systematic review team, the steering group and the GDG. \nSuch diagrams go by different names: analytic frameworks, evidence models, \nlogic models, causal pathways, decision trees, etc. The analytic framework \nillustrates the various components of the key question, the relationships \namong these components and the underlying mechanisms and pathways by \nwhich interventions or other exposures affect health and other outcomes",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains analytic frameworks, which are diagrams showing how an intervention or exposure relates to the population, comparator and outcomes, and the pathways linking intermediate to distal health outcomes. It says they make evidence types and assumptions explicit and help explain GDG agreement and disagreement, and advises the steering group to develop them early, with input from the GDG, review team and methodologist.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-131",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 104,
      "pageEnd": 105,
      "target": "../sections/sec-131-79-references.md",
      "narrative": null,
      "content": "1.\t\nGuyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.; GRADE \nWorking Group. GRADE: an emerging consensus on rating quality of evidence and \nstrength of recommendations. BMJ. 2008;336(7650):924–6. doi: http://dx.doi.org/10.1136/\nbmj.39489.470347.AD PMID: 18436948\n2.\t\nNational Institute for Health and Clinical Excellence. The guidelines manual – Chapter 4. \nLondon: National Institute for Health and Clinical Excellence; 2012 (http://www.nice.org.\nuk/article/pmg6, accessed 11 November 2014).\n3.\t\nGuyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE gu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list of five sources for the question-formulation chapter, including GRADE, NICE guideline manual and US Preventive Services Task Force papers. The extraction also appends the opening paragraphs of the next chapter, which state that WHO recommendations must rest on the best available evidence and on a systematic review guided by key questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-132",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a systematic review?",
      "pageStart": 105,
      "pageEnd": 105,
      "target": "../sections/sec-132-81-what-is-a-systematic-review.md",
      "narrative": null,
      "content": "A systematic review is “a review of a clearly formulated question that uses \nsystematic and explicit methods to identify, select, and critically appraise \nrelevant research, and to extract and analyse data from the studies that are \nincluded in the review” (1). If conducted properly, systematic reviews reduce \nthe risk of bias and improve the reliability and accuracy of conclusions based \non evidence. Systematic reviews should underpin all WHO recommendations on the efficacy, effectiveness, and harms of interventions; the use of \ndiagnostic tests; exposure limits or safety thresholds for vario",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a systematic review and explains that systematic reviews should underpin all WHO recommendations because they reduce bias and improve reliability. It lists seven characteristics of a systematic review, such as focused questions, explicit methods, predefined eligibility criteria, a comprehensive search and risk-of-bias assessment, and begins to note that non-systematic reviews lack these.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-133",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evidence retrieval and synthesis",
      "pageStart": 105,
      "pageEnd": 106,
      "target": "../sections/sec-133-8-evidence-retrieval-and-synthesis.md",
      "narrative": null,
      "content": "93\nWHO handbook for guideline development\n94\nand low-quality systematic reviews should not inform WHO guidelines and \nWHO staff must be able to recognize these and understand their limitations.\nA systematic review is different from a meta-analysis. The latter term \nrefers to the quantitative synthesis (pooling) of an outcome across comparable \nstudies to achieve a pooled estimate of effect (see Section 8.3.5). A systematic \nreview may contain one or more meta-analyses, but this is not a requirement. \nLikewise, a meta-analysis may be a pooled estimate of an outcome from a \ncohort of selected st",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues from the previous section, stating that non-systematic and low-quality systematic reviews should not inform WHO guidelines and that staff must be able to recognize them. It distinguishes a systematic review from a meta-analysis, a quantitative pooling of outcomes, and says pooling studies not found through a systematic review should generally be avoided.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-134",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Identifying and evaluating existing systematic reviews",
      "pageStart": 106,
      "pageEnd": 106,
      "target": "../sections/sec-134-82-identifying-and-evaluating-existing-systemati.md",
      "narrative": null,
      "content": "After scoping the proposed guideline (see Chapter 2) and crafting the key \nquestions (see Chapter 7), the next step in guideline development is to identify \none or more systematic reviews to address each key question. Existing systematic reviews will inform the guideline development process, whether or not \na new systematic review or an update of an existing review will be required.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that after scoping and drafting key questions, the next step is to identify at least one systematic review per key question, since existing reviews inform development whether or not a new review or an update is needed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-135",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Sources for existing systematic reviews",
      "pageStart": 106,
      "pageEnd": 107,
      "target": "../sections/sec-135-821-sources-for-existing-systematic-reviews.md",
      "narrative": null,
      "content": "The search for existing systematic reviews in bibliographic databases, such \nas Medline and EMBASE, should be comprehensive and conducted on the \nbasis of the predefined key question(s). This search can be performed by the \nsteering group or can be commissioned to an external team. Search filters \nspecific for reviews are available in search engines such as PubMed or OVID \nand are useful for preliminary scoping. The characteristics of these search \nfilters vary, however. Furthermore, the filters cannot reliably distinguish \nbetween a systematic review and a non-systematic review or identify hi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes where to find existing systematic reviews: comprehensive searches of databases such as Medline and EMBASE, with the limits of review-specific search filters, and searches of the Cochrane Library for reviews and protocols. It also covers how the GRC Secretariat can link staff to Cochrane, and names DARE, Epistemonikos and Health Systems Evidence as other sources.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-136",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is a new systematic review needed?",
      "pageStart": 107,
      "pageEnd": 108,
      "target": "../sections/sec-136-822-is-a-new-systematic-review-needed.md",
      "narrative": null,
      "content": "It is not always necessary to commission a new systematic review (see \nFig. 8.1). If one or more relevant, current and high-quality systematic reviews \nexist, these should be used. Updates, if needed, are usually less expensive and \ntime-consuming than new reviews.\nWHO handbook for guideline development\n96",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that a new systematic review is not always needed, since relevant, current and high-quality existing reviews should be used and updates are usually cheaper and faster than new reviews. The extraction also includes page-header text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-137",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evaluating the relevance and quality of existing systematic reviews",
      "pageStart": 108,
      "pageEnd": 109,
      "target": "../sections/sec-137-823-evaluating-the-relevance-and-quality-of-exis.md",
      "narrative": null,
      "content": "reviews\nOnce existing systematic reviews are retrieved, the steering group needs \nto assess their relevance, quality, and timeliness before deciding whether \na new review needs to be commissioned. To assess relevance, compare the \nkey question of the existing systematic review to the key questions that were \ndeveloped during the guideline scoping exercise, considering each component of PICO. Most frequently, the existing review does not entirely match \nFig. 8.1.\t\nIs a new systematic review needed?\nYes\nNo\nYes\nNo\nYes\nNo\nPICO: population, intervention, comparator and outcome.\nChapter 8 \nEvidence",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how the steering group assesses existing systematic reviews for relevance (by comparing each PICO component with the guideline's key question), quality and timeliness before deciding whether a new review is needed. It names the AMSTAR, R-AMSTAR and Oxman and Guyatt checklists, warns against using them as scoring tools, and says there is no fixed rule for dismissing a review as out of date. The extraction includes the text of Figure 8.1, a yes-or-no decision flowchart.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-138",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Steps in performing a systematic review",
      "pageStart": 109,
      "pageEnd": 110,
      "target": "../sections/sec-138-83-steps-in-performing-a-systematic-review.md",
      "narrative": null,
      "content": "There are six basic steps in the systematic review process (see Fig. 8.2) (as \ndistinct from the guideline development process described in Chapter 1). \nStep 1, which involves developing and finalizing the key questions, should \nbe performed by the steering group with input from the systematic review \nWHO handbook for guideline development\n98\nteam; the remaining steps are usually performed by the systematic review \nteam in collaboration with the steering group.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the six basic steps of the systematic review process, distinct from the guideline development process, and says the steering group performs step 1 with input from the review team while the review team usually performs the rest in collaboration with the steering group.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-139",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 1: develop and finalize the key questions and the studyeligibility criteria",
      "pageStart": 110,
      "pageEnd": 111,
      "target": "../sections/sec-139-step-1-develop-and-finalize-the-key-questions-an.md",
      "narrative": null,
      "content": "eligibility criteria\nIn addition to specifying a guideline’s key questions in PICO format, it is \nessential to develop explicit and thoughtful criteria for deciding which studies \nto include or not include in the systematic review, be they primary studies or \nexisting reviews. The inclusion and exclusion criteria, as they are known, are \ndrafted by either the steering group or the systematic review team, reviewed \nFig. 8.2.\t\nSteps in developing a systematic review\nDevelop and ﬁnalize  \nthe key questions in PICO format  \nand the study eligibility criteria \nIdentify information sources  \nand sea",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 1 of a systematic review: finalizing the key questions in PICO format and setting explicit study eligibility criteria, which are drafted and agreed by consensus between the steering group and the review team. It lists the additions to PICO for inclusion criteria, such as time frame, setting, study design, language and date range. The extraction also includes the text of Figure 8.2, which lists the six review steps.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-140",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 2: identify information sources and search for originalarticles",
      "pageStart": 111,
      "pageEnd": 113,
      "target": "../sections/sec-140-step-2-identify-information-sources-and-search-f.md",
      "narrative": null,
      "content": "articles\nThe development and finalization of the strategies for searching for evidence \nthat meets the established inclusion criteria is a fundamental step in developing guidelines. It must be done correctly or the quality of the guideline may \nbe compromised. Engaging an expert in information science with specific \nexpertise in bibliographic database searching related to systematic reviews is \nessential. Several individuals, including topic experts and one or more systematic review and guideline methodologists, should review the draft search \nstrategies before they are finalized. The systemat",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 2, designing and running the search for studies, which needs an information science expert, review of draft strategies and consultation with a WHO information scientist. It explains the trade-off between search sensitivity and precision and the need to search for studies from low- and middle-income countries, including regional databases under Global Index Medicus.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-141",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 3: select studies and abstract data",
      "pageStart": 113,
      "pageEnd": 113,
      "target": "../sections/sec-141-step-3-select-studies-and-abstract-data.md",
      "narrative": null,
      "content": "As the first stage in selecting relevant studies, records retrieved from the \nbibliographic databases and from other sources are recorded and assessed \nfor eligibility by examining their titles and abstracts only. This assessment is \nperformed in accordance with the inclusion and exclusion criteria developed \na priori. The full text of articles found to be potentially relevant on the basis \nof their titles and abstracts is retrieved and examined in light of the same \ninclusion criteria in the second stage of study selection. Data from eligible \nstudies are then extracted into pre-defined templ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 3: screening records by title and abstract and then by full text against criteria set in advance, followed by extraction of data into predefined templates, with at least two people working independently. It also requires documenting databases, strategies, counts and exclusion reasons, and showing the flow of studies in a PRISMA diagram.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-142",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 4: assess risk of bias of the individual studies",
      "pageStart": 113,
      "pageEnd": 114,
      "target": "../sections/sec-142-step-4-assess-risk-of-bias-of-the-individual-stu.md",
      "narrative": null,
      "content": "Each study included in a systematic review should be assessed for risk of bias. \nThe main types of bias for intervention studies include selection, attrition, \nperformance and detection bias (22). Nonrandomized studies have similar \nsources of bias, the most important being selection bias, which results in \nthe presence of systematic differences in the baseline characteristics of the \ngroups being compared. Chapter 9 provides additional details on how to \nassess the risk of bias at the individual study level.\nThe following resources may be helpful when determining which instrument to use to as",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 4: assessing the risk of bias of each included study, naming the main bias types (selection, attrition, performance and detection) and pointing to Chapter 9 for detail. It lists four instruments or resources, including Cochrane risk of bias tools and reports from Canadian and United States agencies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-143",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 5: synthesize and report the results and conclusions",
      "pageStart": 114,
      "pageEnd": 115,
      "target": "../sections/sec-143-step-5-synthesize-and-report-the-results-and-con.md",
      "narrative": null,
      "content": "The findings of the systematic review may be synthesized in a narrative \nmanner or quantitatively with a pooled estimate of effect for certain outcomes \n(in other words, a meta-analysis). The review should describe how data were \nhandled and why a given approach to synthesis was taken for each outcome.\nThe results of the systematic reviews are presented to the GDG, along \nwith an assessment of the confidence in the estimates of effect for the critical \nand important outcomes (i.e. quality assessment using GRADE [see Chapter 9]). This presentation generally occurs at an in-person meeting during",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 5, synthesizing and reporting results, either as a meta-analysis when studies are sufficiently homogeneous or as a narrative synthesis when they are not. It explains that results go to the GDG with a GRADE confidence assessment, that meta-analyses give pooled estimates shown in forest plots, and that narrative methods and subgroup analyses should be specified in advance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-144",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Step 6: prepare the final report of the systematic review",
      "pageStart": 115,
      "pageEnd": 115,
      "target": "../sections/sec-144-step-6-prepare-the-final-report-of-the-systemati.md",
      "narrative": null,
      "content": "Systematic reviews conducted in developing WHO guidelines should be \nreported in a standard format using the PRISMA reporting guidelines (20). \nFor some purposes, the methods and results section of the review may be \nall that WHO will require; for other purposes it may require a full report \nwith detailed introduction and discussion sections. GRADE evidence profiles should generally be part of the final report of the systematic review (see \nChapter 9). This report should be sufficiently detailed for WHO staff and the \nGDG to know exactly what was done and what the findings are. However, \nexces",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes step 6: reporting the review in the standard PRISMA format, with GRADE evidence profiles generally included. It says the level of detail may vary by purpose, but the report must make clear what was done and found without excessive study-level detail.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-145",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Including qualitative research",
      "pageStart": 115,
      "pageEnd": 116,
      "target": "../sections/sec-145-84-including-qualitative-research.md",
      "narrative": null,
      "content": "Qualitative data can address certain types of key questions that cannot be \nanswered by quantitative research methods, such as “how” and “why” a given \nintervention produces its effects. Qualitative evidence can help explain, \ninterpret and apply the quantitative results of a systematic review. A synthesis of the findings from qualitative research can be done as part of the \nscoping of the guideline and can help to define and refine the key questions. \nQualitative data may also inform the interpretation of studies on both benefits and harm, address questions on the contextual barriers and faci",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how qualitative research can answer how and why questions, help interpret quantitative results, inform scoping, and illuminate barriers, facilitators, values, preferences and unintended social consequences. It points readers to the GRC intranet site and Cochrane resources for further guidance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-146",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Including other types of data in the systematic review",
      "pageStart": 116,
      "pageEnd": 116,
      "target": "../sections/sec-146-85-including-other-types-of-data-in-the-systemat.md",
      "narrative": null,
      "content": "Many other types and sources of data may be relevant to WHO guidelines. \nFor example, for questions about substances that are potentially toxic to \nhumans or the environment, mechanistic and animal studies may be relevant. Questions about cost and measures of economic efficiency, such as cost–\neffectiveness, may require information on prices from manufacturers or data \nfrom programme evaluations, or may involve modelling based on evidence-\ninformed assumptions. The values and preferences of the people affected by a \nguideline may be explored by conducting a literature search or by generating",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists other data types that may be relevant to WHO guidelines, including mechanistic and animal studies for toxic substances, price and programme data or modelling for cost questions, surveys for values and preferences, and data on feasibility, equity and infrastructure.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-147",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Updating existing systematic reviews",
      "pageStart": 116,
      "pageEnd": 117,
      "target": "../sections/sec-147-86-updating-existing-systematic-reviews.md",
      "narrative": null,
      "content": "Updating an existing systematic review can be a less expensive and more efficient \nway to obtain the synthesis of the evidence required to underpin a recommendation. Updating a systematic review is a complex process, however. Like all the \nmethods outlined in this chapter, it calls for significant experience and training \nif it is to be done well. Once a high-quality and applicable systematic review is \nidentified, its authors should be contacted by the responsible technical officer to \nsee if they are planning to update the review or are doing so already. This is particularly relevant for Coc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses updating an existing systematic review as a cheaper route to the needed evidence that is nonetheless complex and demands experience. It advises contacting the original authors, outlines difficulties such as missing information, outdated methods and unavailable data, and concludes that updating is reasonable when a high-quality, fully reported review using current methods exists.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-148",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How to commission a systematic review",
      "pageStart": 117,
      "pageEnd": 118,
      "target": "../sections/sec-148-87-how-to-commission-a-systematic-review.md",
      "narrative": null,
      "content": "A new systematic review is needed if a relevant, high-quality systematic \nreview is not identified. Or if a high-quality review is not up to date, it will \nneed to be updated. If WHO lacks the appropriate expertise and resources \n(i.e. staff time) for these tasks, then it will have to commission them from an \nexternal source.\nPerforming systematic reviews correctly takes time, expertise and \nresources and the systematic review team needs to be carefully selected. \nMembers of the Cochrane Collaboration may be commissioned to update an \nexisting Cochrane review or to perform a review de novo. Th",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains when and how to commission a systematic review, covering when a new review or update is needed, how cost depends on expertise, question complexity, literature volume and languages, and the use of Cochrane members. It lists five steps for the steering group, from a request for proposals to quality assessment, and requires commissioned teams to know GRADE and produce evidence profiles, with detailed terms of reference.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-149",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic review quality standards",
      "pageStart": 118,
      "pageEnd": 118,
      "target": "../sections/sec-149-88-systematic-review-quality-standards.md",
      "narrative": null,
      "content": "Regardless of the supplier selected, systematic reviews used to inform WHO \nrecommendations must be developed according to the standards outlined by \nthe Cochrane Collaboration in the Cochrane handbook (22). This handbook \nhas a chapter dealing with reviews in public health and health promotion. \nThe evidence-informed standards developed by the Institute of Medicine \nof the United States also provide a useful list of elements for high-quality \nreviews (30).",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that systematic reviews informing WHO recommendations must follow the standards in the Cochrane handbook, and that the Institute of Medicine standards give a useful list of elements of high-quality reviews.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-150",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Systematic review reporting standards",
      "pageStart": 118,
      "pageEnd": 118,
      "target": "../sections/sec-150-89-systematic-review-reporting-standards.md",
      "narrative": null,
      "content": "PRISMA contains reporting standards for systematic reviews (20) and these \nstandards should be the basis for reviews performed to develop WHO guidelines. The PRISMA-Equity 2012 extension (31) includes additional reporting standards related to health equity. The terms of reference for systematic \nreview contractors should include a reference to these standards.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the PRISMA reporting standards, including its equity extension, should be the basis for systematic reviews done for WHO guidelines and should be referenced in contractors' terms of reference.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-151",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 118,
      "pageEnd": 121,
      "target": "../sections/sec-151-810-references.md",
      "narrative": null,
      "content": "1.\t\nGlossary of terms in The Cochrane Collaboration. Version 4.2.5. Oxford: The Cochrane \nCollaboration; 2005. (http://www.cochrane.org/sites/default/files/uploads/glossary.pdf, \naccessed 11 November 2014).\n2.\t\nMontori VM, Wilczynski NL, Morgan D, Haynes RB; Hedges Team. Optimal search strategies \nfor retrieving systematic reviews from Medline: analytical survey. BMJ. 2005;330(7482):68. \ndoi: http://dx.doi.org/10.1136/bmj.38336.804167.47 PMID: 15619601\n3.\t\nLee E, Dobbins M, Decorby K, McRae L, Tirilis D, Husson H. An optimal search filter for \nretrieving systematic reviews and meta-analyses. B",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list of cited sources for the systematic review chapter, covering Cochrane and review-quality tools, databases, and reporting standards. The extraction also appends the opening of the next chapter, which introduces the GRADE approach used by WHO to assess evidence quality and lists public GRADE resources.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-152",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evidence assessment",
      "pageStart": 121,
      "pageEnd": 122,
      "target": "../sections/sec-152-9-evidence-assessment.md",
      "narrative": null,
      "content": "109\nWHO handbook for guideline development\n110",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A divider for the evidence assessment chapter containing the heading, page numbers 109 and 110 and a running header, with no substantive text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-153",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the “quality of the evidence”?",
      "pageStart": 122,
      "pageEnd": 122,
      "target": "../sections/sec-153-91-what-is-the-quality-of-the-evidence.md",
      "narrative": null,
      "content": "Once the evidence has been retrieved and synthesized through a well conducted systematic review, its quality needs to be assessed. In the context of \nevidence syntheses, the GRADE working group defines the quality of the \nevidence as the “extent to which one can be confident that an estimate of \nthe effect or association is correct” (6). In the context of guideline development, the quality of the evidence reflects the confidence that the estimates of \nan effect are adequate to support a particular decision or recommendation. \nAlternative terms to describe the quality of the evidence are “certa",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines the quality of the evidence, in GRADE terms, as the extent to which one can be confident that an effect estimate is correct, and in guideline terms as confidence that estimates are adequate to support a recommendation. It gives the alternative terms certainty of the evidence and confidence in the estimates of effect.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-154",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What are GRADE evidence profiles?",
      "pageStart": 122,
      "pageEnd": 122,
      "target": "../sections/sec-154-92-what-are-grade-evidence-profiles.md",
      "narrative": null,
      "content": "GRADE evidence profiles contain the assessment of the quality of the evidence and a summary of findings across studies for each important or \ncritical outcome and each key question (in PICO format). The GDG uses \nthese summaries as the basis for its discussions and to formulate recommendations (Table  9.1) Outcomes are listed in rows and the judgements \nmade about the factors that determine the quality of the body of evidence \nare described briefly for each outcome, along with a summary of the effect \nestimates for each. Additional details are provided in explanatory footnotes. \nFurther exampl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that GRADE evidence profiles hold the quality assessment and a summary of findings for each important or critical outcome and key question. It says the GDG uses them as the basis for discussion, with outcomes in rows, brief judgements on quality factors and explanatory footnotes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-155",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Who performs the quality assessment?",
      "pageStart": 122,
      "pageEnd": 124,
      "target": "../sections/sec-155-93-who-performs-the-quality-assessment.md",
      "narrative": null,
      "content": "Assessing the evidence and developing evidence summaries are specialized \ntasks that should be performed by a methodological expert with experience \nusing GRADE. Systematic review teams commissioned to support guideline \ndevelopment at WHO must have expertise in using GRADE to conduct evidence assessments.\nChapter 9 \nEvidence assessment\n111\nTable 9.1.\t\nExample of a GRADE evidence profile: is cryotherapy preferable to no treatment in women with \nhistologically confirmed cervical intraepithelial neoplasia? \n  \nCI: confidence interval; CIN: cervical intraepithelial neoplasia; GRADE: Grading of Re",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that evidence assessment is a specialized task for a methodological expert experienced with GRADE, and that commissioned review teams must have this expertise. The extraction also includes Table 9.1, a GRADE evidence profile example on cryotherapy for cervical intraepithelial neoplasia, with its footnotes and very low quality ratings.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-156",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the role of WHO staff in assessing the quality of the evidence?",
      "pageStart": 124,
      "pageEnd": 124,
      "target": "../sections/sec-156-94-what-is-the-role-of-who-staff-in-assessing-th.md",
      "narrative": null,
      "content": "of the evidence?\nWHO staff responsible for developing guidelines need to understand the \nbasic concepts governing the assessment of the quality of the evidence − and \nhow to apply them in GRADE evidence profiles − to supervise commissioned \nwork and advise GDG members. WHO staff who perform systematic reviews \nin house must have an in-depth knowledge of GRADE.\nGDG members should be briefed on how to assess the quality of the evidence before meeting to formulate recommendations. Depending on their \nfamiliarity with guideline development and GRADE, this can be done with a \ncombination of the onl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the role of WHO staff in quality assessment: they must understand GRADE well enough to supervise commissioned work and advise the GDG, and in-house reviewers need in-depth knowledge. It also says GDG members should be briefed on evidence assessment before meetings, using online modules, publications or an introduction by the methodologist or GRC Secretariat.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-157",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How is the quality of the body of evidence assessed for intervention studies?",
      "pageStart": 124,
      "pageEnd": 125,
      "target": "../sections/sec-157-95-how-is-the-quality-of-the-body-of-evidence-as.md",
      "narrative": null,
      "content": "for intervention studies?\nGRADE categorizes the quality of the evidence as high, moderate, low or \nvery low (Table 9.2). These quality ratings apply to the body of evidence for \neach outcome assessed for each key question and not to individual studies. A \njudgement on the risk of bias of each individual study included in the body \nof evidence is needed, however, to assess the quality domain of study limitations (see Section 9.5.1.1).\nFor key questions that address interventions (6–8), the starting point \nor baseline for rating the quality of the evidence is always the study design, \nbroadly cl",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that GRADE rates the quality of a body of evidence for each outcome as high, moderate, low or very low, not individual studies. It states that for intervention questions the starting point is study design, randomized trials versus nonrandomized and observational studies, and advises presenting different designs separately rather than pooling them in a meta-analysis.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-158",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Five factors can lower the quality of the body of evidence for each outcome",
      "pageStart": 125,
      "pageEnd": 131,
      "target": "../sections/sec-158-951-five-factors-can-lower-the-quality-of-the-bo.md",
      "narrative": null,
      "content": "each outcome\nA body of evidence based on RCTs is rated as being of high quality at the \noutset; evidence from nonrandomized trials or observational studies is \nrated as being of low quality. For both types of studies, these initial ratings can be adjusted in light of five factors: limitations in study design and \nexecution; indirectness; imprecision; inconsistency; and publication bias \n(see Fig. 9.1). For a given body of evidence, the ratings are conducted for \neach outcome. This requires detailed knowledge of the individual studies \nincluded in the body of evidence. The factor “limitations i",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that randomized trial evidence starts as high quality and observational evidence as low, and that five factors can lower the rating: study limitations, inconsistency, indirectness, imprecision and publication bias. It includes Table 9.2 defining the four quality levels, advises recording reasons for downgrading in footnotes without rating mechanically, and details the criteria for each factor, such as randomization and blinding for trials and confounding control for observational studies. It also covers how imprecision is judged by sample size and how publication bias is suspected and handled.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/figure-img-p126-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 126,
      "pageEnd": 126,
      "target": "../images/img-p126-1.png",
      "narrative": "draft",
      "content": "The GRADE approach to rating confidence in an estimate of effect. Rows give study design — randomized controlled trials, which start at high confidence, and observational studies, which start at low. Between them, five reasons for lowering confidence (risk of bias, inconsistency, indirectness, imprecision, publication bias) and three for raising it (large effect, dose response, and plausible confounding that would either reduce a demonstrated effect or suggest a spurious one). The right-hand column gives the four resulting levels — high, moderate, low and very low — each shown with the circle notation, from four filled circles down to one.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-159",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Three factors can increase the quality of the evidence from observational studies",
      "pageStart": 131,
      "pageEnd": 132,
      "target": "../sections/sec-159-952-three-factors-can-increase-the-quality-of-th.md",
      "narrative": null,
      "content": "observational studies\nObservational studies are considered low quality evidence from the outset by virtue \nof their design. If, and only if, there are no further limitations, such as additional \nrisk of bias (if, in other words, there is no reason to downgrade their quality), then \nthe assessor can consider upgrading the quality of the evidence according to three \ncriteria: dose−response gradient; direction of plausible bias; and the magnitude of \nthe effect. (It is important to note that factors that could reduce the quality of the \nevidence are always considered before those that could serve",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that observational evidence, low quality from the start, can be upgraded only if there is no reason to downgrade it, using three criteria: a dose-response gradient, a direction of plausible bias that would understate the effect, and a large magnitude of effect. It describes how precision and features such as rapid or consistent effects bear on upgrading, and says upgrades can be by one or two levels.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-160",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How is the overall quality of the evidence determined?",
      "pageStart": 132,
      "pageEnd": 133,
      "target": "../sections/sec-160-96-how-is-the-overall-quality-of-the-evidence-de.md",
      "narrative": null,
      "content": "Guideline developers review all the information from the systematic review \nand, if needed, reassess and make a final decision about which outcomes are \ncritical and which ones are important in light of the recommendations that \nthey aim to formulate. The GDG assigns an overall quality to the evidence, \nbased on a combined rating of the quality of the evidence across all outcomes \nthat are considered critical for answering the key question (i.e. for making a \ndecision or a recommendation).\nGDGs must determine the overall quality of the evidence across all the \ncritical outcomes for each recomm",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how the GDG determines overall quality of evidence across all critical outcomes for a recommendation. The lowest quality among the critical outcomes sets the overall quality, with two exceptions where an outcome proves not to be critical or where higher-quality evidence on other critical outcomes already supports the recommendation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-161",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is GRADE applicable in all situations?",
      "pageStart": 133,
      "pageEnd": 133,
      "target": "../sections/sec-161-97-is-grade-applicable-in-all-situations.md",
      "narrative": null,
      "content": "Confusion and concerns exist as to whether GRADE is applicable to all situations in which a GDG issues a recommendation regarding an intervention. \nThe strength of the GRADE approach rests on the use of a structured framework for the assessment of the quality of the evidence and on the requirements that processes be explicit and judgements transparent. GRADE has \nbeen applied to a wide range of interventions in clinical medicine, public \nhealth and health policy  (18). While the ease of applying the GRADE \napproach will vary according to the type of evidence being assessed, the \ncircumstances",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Considers whether GRADE applies in all situations, concluding that its structured, transparent framework has been used widely and that cases where it cannot be applied are rare and need a rationale approved by the GRC. It says GRADE also covers diagnostic tests, prognosis and baseline risk, while methods for environmental exposures, economic efficiency, network meta-analyses and modelling are still under development.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-162",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 133,
      "pageEnd": 135,
      "target": "../sections/sec-162-98-references.md",
      "narrative": null,
      "content": "1.\t\nGuidelines Review Committee (GRC) [intranet site: available to WHO staff only]. Geneva: \nWorld Health Organization; 2014 (http://intranet.who.int/homes/ker/grc/, accessed 14 \nNovember 2014).\n2.\t\nGRADE working group [website]. The GRADE working group; 2014 (http://www.gradeworkinggroup.org/, accessed 12 November 2014).\n3.\t\nGRADE Online Learning Modules [website]. Ontario: McMaster University; 2014 (http://\ncebgrade.mcmaster.ca/, accessed 12 November 2014).\nWHO handbook for guideline development\n122\n4.\t\nGRADE series in the Journal of Clinical Epidemiology [website]. Maryland Heights: Elsevie",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list for the evidence assessment chapter, citing GRADE working group resources, the GRADE handbook and the GRADE guideline series in the Journal of Clinical Epidemiology, along with Cochrane risk of bias and inconsistency papers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-163",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Factors that determine the direction and strength of recommendations",
      "pageStart": 135,
      "pageEnd": 135,
      "target": "../sections/sec-163-101-factors-that-determine-the-direction-and-str.md",
      "narrative": null,
      "content": "of recommendations\nFour main factors determine the direction and strength of a recommendation in public health (1–5):\n■■\nthe confidence in the estimates of effect of the evaluated evidence (i.e. \nthe quality of the evidence) (see Chapter 9);\n■■\nvalues and preferences related to the outcomes of an intervention or \nexposure;\n■■\nthe balance of benefits and harms; and\n■■\nresource implications.\nIn addition to these four main factors, several other considerations are \nimportant when formulating public health, health system and health policy \nrecommendations. These factors overlap with the main four",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Names the four main factors that determine the direction and strength of a recommendation: quality of the evidence, values and preferences, the balance of benefits and harms, and resource implications. It begins a list of four further considerations that GDGs may discuss separately, starting with the priority of the problem.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-164",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Developing recommendations",
      "pageStart": 135,
      "pageEnd": 136,
      "target": "../sections/sec-164-10-developing-recommendations.md",
      "narrative": null,
      "content": "123\nWHO handbook for guideline development\n124\n124\n■■\nequity and human rights;\n■■\nacceptability; and\n■■\nfeasibility.\nTable 10.1 lists the detailed GRADE criteria that determine the direction and strength of a recommendation and describes how they influence the recommendation. These criteria are also included in the GRADE \nguideline development tool (6). To formulate a recommendation, the GDG \nconsiders each factor in turn and judges its importance and effect on the \nrecommendation.\nTable 10.1.\t Factors that determine the direction and strength of a \nrecommendation\nFactor\nHow the factor influen",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the list of additional considerations (equity and human rights, acceptability and feasibility) and says Table 10.1 sets out the GRADE criteria the GDG considers in turn to judge each factor's effect. The extraction mostly contains page numbers, running headers and the table's column headings.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-165",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Quality of the evidence",
      "pageStart": 136,
      "pageEnd": 136,
      "target": "../sections/sec-165-1021-quality-of-the-evidence.md",
      "narrative": null,
      "content": "The quality of the evidence across outcomes critical to decision-making will inform the \nstrength of the recommendation. The higher the quality of the evidence, the greater the \nlikelihood of a strong recommendation.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States, as the first row of Table 10.1, that the quality of the evidence across critical outcomes informs recommendation strength, with higher quality making a strong recommendation more likely.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-166",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Values and preferences",
      "pageStart": 136,
      "pageEnd": 137,
      "target": "../sections/sec-166-1022-values-and-preferences.md",
      "narrative": null,
      "content": "This describes the relative importance assigned to health outcomes by those affected by \nthem; how such importance varies within and across populations; and whether this importance or variability is surrounded by uncertainty. The less uncertainty or variability there is \nabout the values and preferences of people experiencing the critical or important outcomes, \nthe greater the likelihood of a strong recommendation.\nBalance of benefits and harms\nThis requires an evaluation of the absolute effects of both benefits and harms (or downsides) \nof the intervention and their importance. The greater t",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the remaining rows of Table 10.1, describing how each factor affects the likelihood of a strong recommendation: values and preferences, balance of benefits and harms, resource implications, priority of the problem, equity and human rights, acceptability and feasibility. The text under the heading is the table body, which says that greater certainty, net benefit or advantage on each factor makes a strong recommendation more likely.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-167",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Detailed criteria that should be considered when moving from evidence to recommendations",
      "pageStart": 137,
      "pageEnd": 138,
      "target": "../sections/sec-167-102-detailed-criteria-that-should-be-considered.md",
      "narrative": null,
      "content": "moving from evidence to recommendations\n10.2.1 Quality of the evidence\nThe quality of the evidence – the degree of confidence in the estimates of \neffect – is a key factor in determining the strength of a recommendation \n(see Chapter 9). The higher the quality of the evidence, the more likely a \nstrong recommendation is warranted. Uncertainty can surround both benefits and harms and if the corresponding evidence associated with one or \nmore important or critical outcomes is of low or very low quality, a conditional recommendation is much more likely.\n10.2.2 Values and preferences\nThe values an",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives detailed guidance on the first two criteria for moving from evidence to recommendations. It explains that higher quality evidence favours a strong recommendation, and that values and preferences concern how people rate outcomes, can be gathered through reviews, primary surveys or GDG experience, and call for a conditional recommendation when uncertain or variable.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-168",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Balance of benefits and harms",
      "pageStart": 138,
      "pageEnd": 138,
      "target": "../sections/sec-168-1023-balance-of-benefits-and-harms.md",
      "narrative": null,
      "content": "When considering the balance between an intervention’s or exposure’s benefits and harms, the GDG should examine the magnitude of the effects and \nthe relative importance of the outcomes, including any disadvantages or \ninconveniences associated with the intervention (as informed by data on \nvalues and preferences). If the benefits clearly outweigh the harms, a strong \nrecommendation is likely to be issued. On the other hand, a conditional \nrecommendation is more likely if there is uncertainty about the balance of \nbenefits versus harms or when the anticipated net benefits are small.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the GDG weighs the size of benefits and harms and the relative importance of outcomes, issuing a strong recommendation when benefits clearly outweigh harms and a conditional one when the balance is uncertain or the net benefit is small.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-169",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Resource implications",
      "pageStart": 138,
      "pageEnd": 139,
      "target": "../sections/sec-169-1024-resource-implications.md",
      "narrative": null,
      "content": "Resource considerations are generally included in the formulation of recommendations, unless there is a deliberate and explicit decision to omit them. \nIn considering resource implications, the GDG can be informed by a formal \neconomic evaluation based on estimates collected during evidence retrieval \nand by modelling of cost–benefit and cost–effectiveness. If a full evaluation \nis not possible, resource implications can be anticipated and described in a \nqualitative manner. The more advantageous or disadvantageous the resource \nimplications are, the greater the likelihood of a strong recommen",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that resource implications are normally included in recommendations and may be informed by formal economic evaluation, modelling or qualitative description. It says clearer advantages or disadvantages favour a strong recommendation, while uncertain costs favour a conditional one.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-170",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Priority of the problem",
      "pageStart": 139,
      "pageEnd": 139,
      "target": "../sections/sec-170-1025-priority-of-the-problem.md",
      "narrative": null,
      "content": "GDGs should consider − and be provided with − evidence about the burden \nof disease and the baseline risk, prevalence or incidence of the problem that \nis addressed. These considerations are particularly important when the GDG \nneeds to prioritize across interventions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that GDGs should be given evidence on burden of disease, baseline risk, prevalence or incidence, which matters especially when prioritizing across interventions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-171",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Equity and human rights",
      "pageStart": 139,
      "pageEnd": 139,
      "target": "../sections/sec-171-1026-equity-and-human-rights.md",
      "narrative": null,
      "content": "Interventions have implications for the progressive realization of the right \nto health and the options given in a guideline can reduce or increase health \ninequities. Policies or programmes that increase equity or reduce inequity \nare generally assigned higher priority by GDGs than those that do not. \nGDGs must carefully consider how the intervention might affect equity and \nhuman rights and strive to formulate recommendations in line with WHO’s \ncore principles. The greater the likelihood that the intervention will reduce \ninequities or increase equity and the greater the accessibility of an",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that GDGs must consider how an intervention affects equity and human rights, giving higher priority to those that increase equity, and that greater likelihood of reducing inequities and wider accessibility make a strong recommendation more likely.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-172",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acceptability",
      "pageStart": 139,
      "pageEnd": 140,
      "target": "../sections/sec-172-1027-acceptability.md",
      "narrative": null,
      "content": "The lower the acceptability of an intervention to the most important stakeholders, the lower the likelihood that it will be recommended. Or, if it is recommended, the more likely it is that a strategy to address concerns about \nacceptability during implementation will be included in the guideline with \nthe recommendations. Acceptability is affected by several factors, such as who \nbenefits from an intervention and who is harmed by it; who pays for it or saves \nmoney on account of it; and when the benefits, harms and costs occur. Lack \nof acceptability may revolve around the distribution of the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that lower acceptability of an intervention to key stakeholders makes a recommendation less likely or calls for an implementation strategy to address concerns. It lists what shapes acceptability, including who benefits, is harmed or pays, timing of effects and ethical or legal issues.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-173",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Feasibility",
      "pageStart": 140,
      "pageEnd": 140,
      "target": "../sections/sec-173-1028-feasibility.md",
      "narrative": null,
      "content": "The less feasible an option is (i.e. the greater the barriers to its implementation), the lesser the likelihood that the intervention will be strongly recommended. Feasibility is influenced by the resources available, programmatic \nconsiderations, the existing and the necessary infrastructure and training, \nand many other factors.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that less feasible options, with greater implementation barriers, are less likely to be strongly recommended, and that feasibility depends on resources, programme factors, infrastructure and training.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-174",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evidence-to-recommendation tables",
      "pageStart": 140,
      "pageEnd": 140,
      "target": "../sections/sec-174-103-evidence-to-recommendation-tables.md",
      "narrative": null,
      "content": "Evidence-to-recommendation tables depict how the factors that determine \nthe direction and strength of a recommendation inform the process of developing the recommendation. These tables enhance the transparency of the \nprocess, focus the discussions of the GDG and permit recording of the judgements made about each factor and how each one contributed to the recommendation. Because these factors overlap to some extent, the GDG should, \nat a minimum, document its judgements on the four main factors. The systematic review team and the methodologist can provide most of the information required for",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes evidence-to-recommendation tables, which show how each factor informs a recommendation, improve transparency, focus discussion and record judgements. It says the GDG should at least document the four main factors and that the review team and methodologist can prepare much of the table beforehand.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-175",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The strength of the recommendation",
      "pageStart": 140,
      "pageEnd": 141,
      "target": "../sections/sec-175-104-the-strength-of-the-recommendation.md",
      "narrative": null,
      "content": "The strength of a recommendation expresses the degree to which the GDG \nis confident in the balance between the desirable and undesirable consequences of implementing the recommendation. When a GDG is very certain about this balance (i.e. the desirable consequences clearly outweigh the \nundesirable consequences), it issues a strong recommendation in favour of \nan intervention. When it is uncertain about this balance, however, it issues \na conditional (or “weak”) recommendation. Table 10.2 provides an aid to \ninterpreting the strength of a recommendation.\nChapter 10 \nDeveloping recommendations",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that recommendation strength reflects the GDG's confidence in the balance of desirable and undesirable consequences, with a strong recommendation issued when confident and a conditional (weak) one when uncertain. It refers to Table 10.2 as an interpretive aid.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-176",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Strong recommendations",
      "pageStart": 141,
      "pageEnd": 141,
      "target": "../sections/sec-176-1041-strong-recommendations.md",
      "narrative": null,
      "content": "Strong recommendations communicate the message that the guideline is \nbased on the confidence that the desirable effects of adherence to the recommendation outweigh the undesirable consequences. Strong recommendations are uncommon because the balance between the benefits and harms \nof implementing a recommendation is rarely certain. In particular, GDGs \nneed to be cautious when considering making strong recommendations on \nthe basis of evidence whose quality is low or very low.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that strong recommendations convey confidence that desirable effects outweigh undesirable ones, are uncommon because the balance is rarely certain, and call for caution when evidence quality is low or very low.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-177",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Conditional or weak recommendations",
      "pageStart": 141,
      "pageEnd": 142,
      "target": "../sections/sec-177-1042-conditional-or-weak-recommendations.md",
      "narrative": null,
      "content": "Recommendations that are conditional or weak are made when a GDG is less \ncertain about the balance between the benefits and harms or disadvantages \nof implementing a recommendation. Conditional recommendations generally include a description of the conditions under which the end-user should \nor should not implement the recommendation.\nTable 10.2.\t Interpretation of strong and conditional recommendations \nfor an intervention\nAudience\nStrong recommendation\nConditional recommendation\nPatients\nMost individuals in this situation would want the \nrecommended course of action; only a small proportion",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that conditional (weak) recommendations are made when the guideline group is less certain about the balance of benefits and harms, and that they usually state the conditions for implementing them. Includes a table interpreting strong versus conditional recommendations for patients, clinicians and policy-makers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-178",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Formulating recommendations",
      "pageStart": 142,
      "pageEnd": 142,
      "target": "../sections/sec-178-105-formulating-recommendations.md",
      "narrative": null,
      "content": "The evidence-to-recommendation tables depict not only the evidence and \njudgements leading to a recommendation, but also the justifications for the \nrecommendation’s direction and strength. They also describe the subgroups \nconsidered, the process used to formulate recommendations (e.g. if voting \ntook place) and key issues surrounding implementation, evaluation and \nmonitoring (see Chapter 13) as well as research gaps.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how evidence-to-recommendation tables record the evidence, judgements and justification for a recommendation's direction and strength, along with subgroups, the formulation process, implementation issues and research gaps.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-179",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Reaching agreement on recommendations",
      "pageStart": 142,
      "pageEnd": 142,
      "target": "../sections/sec-179-1051-reaching-agreement-on-recommendations.md",
      "narrative": null,
      "content": "Draft recommendations can be prepared either by the steering group \nbefore the GDG meets to formulate recommendations, or during the meeting by the GDG itself. Under the leadership of the chair, the GDG reviews \nand discusses the GRADE evidence profiles presented by a representative \nof the systematic review team. In addition, the GDG considers other relevant criteria and evidence as discussed above. If the steering group has \nnot drafted the evidence-to-decision tables before the GDG meeting, the \nGDG assesses each of the factors in Table 10.1 at its meeting and completes \nthe evidence-to-dec",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how draft recommendations are prepared by the steering group or the guideline group and reviewed against GRADE evidence profiles and evidence-to-decision tables at the meeting. States that the group must agree on direction and strength by consensus, and that strong disagreement points to a conditional recommendation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-180",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Writing recommendations",
      "pageStart": 142,
      "pageEnd": 143,
      "target": "../sections/sec-180-106-writing-recommendations.md",
      "narrative": null,
      "content": "Recommendations need to be clear and actionable, reflect the PICO format \nand contain an indication of their strength and of the quality of the evidence \non which they are based. Outcomes should generally not be mentioned in \nthe recommendation to avoid the impression that only single outcomes are \nrelevant or were considered.\nThe language of each recommendation is critically important. Wherever possible, it should be consistent across all recommendations in a guideline, which \nshould be written in the active voice. GRADE recommends using terms or phrases \nChapter 10 \nDeveloping recommendation",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out how recommendations should be written: clear, actionable, in PICO format, in the active voice, with consistent wording and an indication of strength and evidence quality. Advises on terms such as should and suggest, prefers explicit wording like recommending against over the ambiguous not recommended, and says each recommendation needs a justification, remarks on context and links to its supporting evidence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-181",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "When not to make recommendations",
      "pageStart": 143,
      "pageEnd": 144,
      "target": "../sections/sec-181-107-when-not-to-make-recommendations.md",
      "narrative": null,
      "content": "In rare situations, a GDG may decide that the evidence is not sufficient to be \nable to formulate a recommendation. For instance, it may not be appropriate \nto make a recommendation when no evidence about the effects of an intervention is found, in which case the following statement could be included: \n“No recommendation can be made because evidence on the effectiveness (or \nharms) of intervention X was not identified.”\nInstead of providing a recommendation, it is sometimes appropriate to \npublish the results of the systematic review showing a lack of studies, or \nan overview of the available",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that a guideline group may occasionally decide the evidence is insufficient to make a recommendation, and gives a model statement for such cases. Stresses that this should be exceptional, that the lack of evidence must be stated openly, and that case reports or national experience can instead support a documented conditional recommendation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-182",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Future research",
      "pageStart": 144,
      "pageEnd": 144,
      "target": "../sections/sec-182-108-future-research.md",
      "narrative": null,
      "content": "When gaps in the evidence are such that significant uncertainty exists with \nrespect to the balance of an intervention’s benefits and harms, such knowledge gaps should be described and questions and methods for addressing the \ngaps should be suggested. The research agenda can be prioritized, if appropriate. This section of the guideline document will inform future recommendations and guidelines. In formulating questions for future research, \nthe GDG should be as specific as possible about what is needed and why. The \nPICO framework is also very useful for this purpose.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that significant evidence gaps should be described in the guideline with suggested questions and methods for future research, possibly prioritized and framed using PICO.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-183",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 144,
      "pageEnd": 145,
      "target": "../sections/sec-183-109-references.md",
      "narrative": null,
      "content": "1.\t\nAndrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of \nrecommendations. J Clin Epidemiol. 2013;66(7):719–25. doi: http://dx.doi.org/10.1016/j.\njclinepi.2012.03.013 PMID: 23312392\n2.\t\nGuyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al.; GRADE Working \nGroup. Going from evidence to recommendations. BMJ. 2008;336(7652):1049–51. doi: \nhttp://dx.doi.org/10.1136/bmj.39493.646875.AE PMID: 18467413\n3.\t\nGuyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list of publications cited in the chapter on developing recommendations, mostly on GRADE and moving from evidence to recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-184",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a rapid advice guideline?",
      "pageStart": 145,
      "pageEnd": 145,
      "target": "../sections/sec-184-111-what-is-a-rapid-advice-guideline.md",
      "narrative": null,
      "content": "In response to a public health emergency, WHO must provide global leadership \nand timely guidance in the form of an evidence-informed guideline produced \nwithin one to three months. The steering group for such a rapid advice guideline must follow all of the basic steps for guideline development as described in \nthis handbook, but with modifications to meet the accelerated timeline.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the rapid advice guideline as an evidence-informed guideline produced within one to three months in response to a public health emergency, following the usual steps with modifications for the accelerated timeline.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-185",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is a rapid review?",
      "pageStart": 145,
      "pageEnd": 146,
      "target": "../sections/sec-185-112-what-is-a-rapid-review.md",
      "narrative": null,
      "content": "Because recommendations issued by WHO need to be based on the best \navailable evidence, guidelines typically draw on evidence from well conducted and reported systematic reviews, whether they exist already or are \nundertaken to inform the development of the guideline. Producing systematic reviews can take varying amounts of time – from six months to more \nthan one year − depending on the complexity of the topic and the available resources. In a public health emergency, conducting a conventional or \nstandard systematic review de novo may not be feasible. Rapid reviews have \nemerged as a streaml",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines a rapid review as an evidence review using accelerated or modified systematic review methods, explaining that a standard systematic review can take six months to over a year and may be infeasible in an emergency. States that rapid reviews keep core values such as transparency and bias minimization, and lists efficiencies such as narrower scope, fewer outcomes, more reviewers in parallel and streamlined processes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-186",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the evidence on the validity and impact of rapid reviews and rapid advice guidelines?",
      "pageStart": 146,
      "pageEnd": 146,
      "target": "../sections/sec-186-113-what-is-the-evidence-on-the-validity-and-imp.md",
      "narrative": null,
      "content": "rapid reviews and rapid advice guidelines?\nTo date limited guidance has been provided on when and how to conduct \na rapid review, and few data exist on how a rapid review performs compared with a standard systematic review. Available data do point to wide \nand increasing interest − and great variability − in the approaches used and \nlevel of reporting of the methods and results across organizations producing rapid reviews and rapid advice guidelines (2–4). Rapid reviews may be \nnarrower in scope and more tailored to the needs of the commissioning \nbody and intended users than standard systemat",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that little guidance and few data exist on how rapid reviews perform against standard systematic reviews, and that approaches and reporting vary widely across organizations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-187",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is a rapid advice guideline needed?",
      "pageStart": 146,
      "pageEnd": 147,
      "target": "../sections/sec-187-114-is-a-rapid-advice-guideline-needed.md",
      "narrative": null,
      "content": "The first and most important question to consider is whether a rapid advice \nguideline is appropriate in the setting of the public health emergency at hand. \nChapter 11 \nRapid advice guidelines in the setting of a public health emergency\n135\n135\nThe need for, and appropriateness of, undertaking a rapid advice guideline, \nin light of the potential limitations of this approach, warrant consideration \nin the initial planning stage of a rapid advice guideline. Several issues need \nto be considered when deciding whether to develop a rapid advice guideline instead of a standard guideline, or to defe",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the first question is whether a rapid advice guideline is appropriate in the emergency, as opposed to a standard guideline or deferring development, and that this should be considered at the planning stage.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-188",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the type of emergency and the risk to public health?",
      "pageStart": 147,
      "pageEnd": 147,
      "target": "../sections/sec-188-1141-what-is-the-type-of-emergency-and-the-risk.md",
      "narrative": null,
      "content": "health?\nThe first step is to examine the public health event that is driving the request \nfor a rapid advice guideline. Emergencies may be classified as natural, technological, or conflict-related and may be of sudden onset (e.g. earthquakes, tsunamis, chemical crises) or more gradual onset (e.g. deteriorating situations in \narmed conflict, progressive disease outbreaks, drought or food insecurities). \nAll types of emergencies can evolve into prolonged or protracted situations.\nWHO and Member States use the manual entitled Rapid risk assessment \nof acute public health events to assess “any out",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how to examine the type of emergency driving the request, classing emergencies as natural, technological or conflict-related and sudden or gradual. Refers to WHO's rapid risk assessment manual and the Emergency Response Framework, including the grading of emergencies from Grade 1 to Grade 3.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-189",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Is the event novel?",
      "pageStart": 147,
      "pageEnd": 148,
      "target": "../sections/sec-189-1142-is-the-event-novel.md",
      "narrative": null,
      "content": "WHO staff may consider producing a rapid advice guideline primarily in the \nface of one of two types of events:\n■■\na new situation (e.g. a new strain of influenza; the Middle East respiratory syndrome [MERS] coronavirus; or an earthquake); or\n■■\nan event encountered previously but causing problems in a different \ncontext (e.g. a natural disaster; a change in disease pattern such as the \nEbola virus disease in West Africa in 2014; or a prolonged armed conflict compounded by a disease outbreak).\nWHO handbook for guideline development\n136\n136\nIf the event is not novel, high-quality guidelines tha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that a rapid advice guideline is mainly considered for a new situation or a known event in a new context, and that for non-novel events suitable high-quality guidelines may already exist.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-190",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Does uncertainty need to be urgently addressed?",
      "pageStart": 148,
      "pageEnd": 148,
      "target": "../sections/sec-190-1143-does-uncertainty-need-to-be-urgently-addres.md",
      "narrative": null,
      "content": "Guidelines are indicated when there is uncertainty about what to do in a specific situation. Rapid advice guidelines are no different. WHO staff may be \nuncertain about what advice to provide, or there may be uncertainty in the \nfield, with different players having different viewpoints and approaches. The \nquestion here is how quickly the uncertainty needs to be addressed.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that rapid advice guidelines, like others, address uncertainty about what to do, and that the question is how quickly it must be resolved.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-191",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "What is the anticipated time frame for the event?",
      "pageStart": 148,
      "pageEnd": 148,
      "target": "../sections/sec-191-1144-what-is-the-anticipated-time-frame-for-the.md",
      "narrative": null,
      "content": "The intent of rapid advice guidelines is to provide urgently needed, evidence-\ninformed recommendations that can be implemented within one to three months \nof the appearance of an unfolding situation or crisis. If from the outset an event \nis judged likely to persist beyond six months, a rapid advice guideline may not \nbe suitable. It is important to weigh the impact of developing recommendations \nusing standard processes and timelines, rather than produce a guideline that \nmay be prone to serious limitations under an accelerated timeline.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that rapid advice guidelines aim to give recommendations implementable within one to three months, and may be unsuitable if the event is expected to last beyond six months.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-192",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Will the rapid advice guideline be rapidly implemented?",
      "pageStart": 148,
      "pageEnd": 149,
      "target": "../sections/sec-192-1145-will-the-rapid-advice-guideline-be-rapidly.md",
      "narrative": null,
      "content": "Rapid advice guidelines should only be developed if a mechanism is in place \nfor disseminating and implementing them, and if implementing the recommendations is feasible in the context of the emergency. Various factors need \nto be carefully considered before embarking on the guideline development \nprocess. They include the existence of health systems and other infrastructure, the acceptability of the proposed intervention, the training requirements involved, and resource availability.\nIn summary, the decision to develop a rapid advice guideline should be \ninformed by the above-mentioned factor",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says a rapid advice guideline should be developed only if dissemination and implementation mechanisms exist and are feasible, considering health systems, acceptability, training and resources. Summarizes the conditions for going ahead: a clear need, manageable scope, adequate expertise and funding, and an implementation plan.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-193",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How is a rapid advice guideline developed?",
      "pageStart": 149,
      "pageEnd": 149,
      "target": "../sections/sec-193-115-how-is-a-rapid-advice-guideline-developed.md",
      "narrative": null,
      "content": "The basic steps for developing a rapid advice guideline are identical to those \nthat apply to standard guidelines, as outlined in Chapter 1. There are some \ndifferences and additional considerations, however, when developing a rapid \nadvice guideline: the steps involved are depicted in Table 11.1.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the development of rapid advice guidelines as following the same basic steps as standard guidelines, with differences summarized in a table.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-194",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Consult the GRC Secretariat early",
      "pageStart": 149,
      "pageEnd": 149,
      "target": "../sections/sec-194-1151-consult-the-grc-secretariat-early.md",
      "narrative": null,
      "content": "It is particularly important for the responsible technical officer of a rapid \nadvice guideline to contact the GRC Secretariat early in the guideline development process. The GRC and the Secretariat will provide guidance as to \nwhether a rapid advice guideline is appropriate in the situation at hand. In \naddition, the Secretariat can assist in developing the planning proposal and \nidentifying a review team and a guideline methodologist. The GRC needs \nto approve the development of a rapid advice guideline at the planning proposal stage, or else the final guideline cannot be reviewed and assess",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises the responsible technical officer to contact the Guideline Review Committee Secretariat early for guidance, help with the planning proposal and review team, and notes the committee must approve development at the planning stage for accelerated review.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-195",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Formulate the various groups involved in guideline development",
      "pageStart": 149,
      "pageEnd": 152,
      "target": "../sections/sec-195-1152-formulate-the-various-groups-involved-in-gu.md",
      "narrative": null,
      "content": "development\nTo determine the most appropriate scope and key questions, the steering \ngroup needs to be quickly assembled and all members fully engaged in the \nguideline development process. The chair and other potential members of \nthe GDG should also be identified early and approached regarding their \ninterest and availability within the set time frame. Ideally one or more key \nmembers of the GDG should be available immediately to provide feedback \non the proposed scope and key questions. If the draft final guideline is to \nundergo peer review, potential reviewers − individuals or organizatio",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how to assemble the steering group, guideline development group and peer reviewers quickly, including expertise in ethical, social, legal, equity, gender and human rights issues. Presents a table of the steps of rapid advice guideline development across planning, development, and publishing and updating phases, naming who is responsible and the key points that differ from standard guidelines. Notes that human rights and gender issues often arise early in a response.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-196",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Scope the rapid advice guideline and define the key questions",
      "pageStart": 152,
      "pageEnd": 152,
      "target": "../sections/sec-196-1153-scope-the-rapid-advice-guideline-and-define.md",
      "narrative": null,
      "content": "questions\nOnce the need for a rapid advice guideline has been established and at least \nthe core members of the steering group have been identified, work should \nbegin on defining the scope of the guideline and on developing the key questions in PICO format. A rapid advice guideline will most likely provide recommendations on the benefits and harms of interventions: it is less likely to \ndeal with matters concerning diagnosis, prognosis or risk thresholds.\nWHO staff, with the assistance of an information specialist, should perform a rapid scoping exercise to provide a general sense of the exte",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how to define the scope and PICO key questions once the need is established, noting such guidelines mostly address benefits and harms of interventions. Describes a rapid scoping search of sources such as MEDLINE, the Cochrane Library and existing WHO guidance, limited to one or two days and summarized in the planning proposal.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-197",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Prepare the planning proposal for the GRC",
      "pageStart": 152,
      "pageEnd": 153,
      "target": "../sections/sec-197-1154-prepare-the-planning-proposal-for-the-grc.md",
      "narrative": null,
      "content": "Like standard guidelines, rapid advice guidelines require that a planning proposal be submitted to the GRC for review and disposition. The content, level \nof detail and format are the same as those outlined in Chapter 4. Although \nthe planning proposal takes time to prepare, it is nonetheless essential for \nthe development of a rapid advice guideline, since it serves as a point of reference for the steering group, the systematic review team and the guideline \nmethodologist. The planning proposal describes both the processes and procedures to be used to develop the guideline and provides a deta",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that a rapid advice guideline still needs a planning proposal submitted to the review committee, in the same format as for standard guidelines. Says it should be detailed, kept up to date as a living document with rationale for changes, because the rapid review process is more fluid and documentation supports transparency.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-198",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "How do rapid reviews compare with systematic reviews?",
      "pageStart": 153,
      "pageEnd": 153,
      "target": "../sections/sec-198-116-how-do-rapid-reviews-compare-with-systematic.md",
      "narrative": null,
      "content": "reviews?\nThe core principles of evidence searching and retrieval, including transparency and reproducible and explicit methods, apply to rapid reviews. There are \nkey differences, however, between searching in the context of a rapid review \nand of a standard systematic review. The rapid review has more restricted \nsearch criteria; looks to existing high-quality systematic reviews as the first \nline of evidence; involves a more targeted and iterative procedure for screening the literature and for data analysis and synthesis; places less emphasis on \nmeta-analyses; and involves a concise and abb",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Contrasts rapid with standard systematic reviews: restricted search criteria, existing systematic reviews as first evidence, targeted iterative screening, less emphasis on meta-analysis and shorter reports, while keeping transparency and explicit methods.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-199",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Types of rapid reviews",
      "pageStart": 153,
      "pageEnd": 155,
      "target": "../sections/sec-199-1161-types-of-rapid-reviews.md",
      "narrative": null,
      "content": "The reviews that underpin rapid advice guidelines may be categorized into \nfour basic types: a full, standard systematic review performed rapidly; a \nreview involving a variety of abbreviated methods and including only systematic reviews and existing guidelines; a review of primary studies and \nexisting systematic reviews, or a review of primary studies only. Fig 11.1 \noutlines the types of rapid reviews, along with their similarities and distinguishing features.\nWHO handbook for guideline development\n142\n142\nFig. 11.1.\t\nTypes of rapid review and their characteristics\nGRADE: Grading of Recomme",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes four types of rapid review, from a full systematic review done quickly to reviews of only systematic reviews and guidelines, or of primary studies, and refers to a figure outlining their features.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/figure-img-p154-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 154,
      "pageEnd": 154,
      "target": "../images/img-p154-1.png",
      "narrative": "draft",
      "content": "A comparison of four types of rapid review — a traditional systematic review conducted rapidly, a rapid review of systematic reviews, a rapid review of systematic reviews plus primary studies, and a rapid review of primary studies only — across twelve methodological dimensions. The traditional review allows up to 16 weeks where the three rapid forms allow up to 12. It differs from them throughout: no restrictions on literature search or number of databases against restrictions and 2–3 databases; complete data-extraction verification against one reviewer with selected verification; outcomes restricted to four or fewer against two to four with more if available. Rows also cover question types, number of questions, use of systematic reviews, grey literature, screening, study designs included, risk-of-bias assessment, and assessment of the quality of the body of evidence.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-200",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Steps in the rapid review process",
      "pageStart": 155,
      "pageEnd": 155,
      "target": "../sections/sec-200-117-steps-in-the-rapid-review-process.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-201",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Select the types of evidence to be collected and identify the appropriate sources",
      "pageStart": 155,
      "pageEnd": 155,
      "target": "../sections/sec-201-1171-select-the-types-of-evidence-to-be-collecte.md",
      "narrative": null,
      "content": "the appropriate sources\nDepending on the nature of the question being asked, the purpose of the \nrapid review and the magnitude of the literature on the topic, various types \nof evidence may be targeted. In most cases the emphasis will be placed on \nlocating and summarizing evidence from relevant and high-quality “off-the-\nshelf’ systematic reviews or guidelines. In the absence of systematic reviews, \nhigh-quality and/or recent primary studies may also be included. Landmark \npapers may also be included for reference. Finally, quasi-experimental and/\nor observational studies of high quality may",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains which evidence to target and where to look, emphasizing existing high-quality systematic reviews and guidelines, then primary studies, landmark papers and good observational studies as needed. Notes that rapid reviews usually search only two to three key databases.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-202",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Develop search strategies",
      "pageStart": 155,
      "pageEnd": 156,
      "target": "../sections/sec-202-1172-develop-search-strategies.md",
      "narrative": null,
      "content": "Concepts need to be well defined with search terms that include both medical subject headings (MeSH) and text words. It is important that the draft \nsearch strategy be reviewed by:\n■■\nat least one other member of the rapid review team;\n■■\none or more content experts, such as WHO technical staff; and\n■■\na WHO information specialist with expertise in systematic reviews.\nValidated search filters may be very useful when performing a rapid \nreview (see Chapter 8). The search filters of most interest are those that comprise index terms relating to study type and design, such as randomized \ncontrolle",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains how to build rapid review search strategies, using subject headings and text words, with review by a team member, content experts and an information specialist. Notes that study-design filters can surface top evidence first and that a rapid review may favour precision over recall, with the choice reported.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-203",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Search for grey literature",
      "pageStart": 156,
      "pageEnd": 156,
      "target": "../sections/sec-203-1173-search-for-grey-literature.md",
      "narrative": null,
      "content": "A search for grey literature should be considered but needs to be limited. For \nexample, the websites of relevant organizations can quickly provide relevant \ndata. An information specialist at WHO’s headquarters library should be \nconsulted regarding the proposed strategy for searching the grey literature.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises that a limited grey literature search, such as checking relevant organizations' websites, may be considered, in consultation with a WHO library information specialist.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-204",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Common search restrictions",
      "pageStart": 156,
      "pageEnd": 157,
      "target": "../sections/sec-204-1174-common-search-restrictions.md",
      "narrative": null,
      "content": "Several common eligibility restrictions should be considered when developing search strategies in the context of a rapid review (Box 11.1) (1). Potential \nrestrictions should be discussed among steering group members and with \nthe review team information specialist to optimally balance precision and \nrecall of the search strategies.\nSearch strategies for a rapid review will generally have language restrictions, since translation is time-consuming. The languages of inclusion \nshould be carefully selected based on the guideline topic. For example, a \nrapid review on personal protective equipment",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses common eligibility restrictions for rapid review searches, especially language limits chosen by topic, illustrated by an Ebola protective equipment review limited to English and French. Says restrictions must be documented in the proposal, report and guideline, and that titles in excluded languages should be listed in an appendix.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-205",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Other strategies for identifying relevant literature",
      "pageStart": 157,
      "pageEnd": 158,
      "target": "../sections/sec-205-1175-other-strategies-for-identifying-relevant-l.md",
      "narrative": null,
      "content": "In the context of a new situation or event, the best (and perhaps only) data \nmight come from the acquisition and analysis of emerging information in real \ntime. In the Ebola virus disease outbreak in West Africa in 2014, essentially no \nrelevant comparative data were obtained through a systematic review of the \npublished literature. WHO staff therefore rapidly devised and implemented \na survey of repatriated health-care workers to gather information on these \nworkers’ experiences with various types of personal protective equipment.\nBox 11.1.\t\nCommon search restrictions for rapid reviews\nSourc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes other ways to find evidence, such as real-time data collection like the survey of repatriated health workers during the 2014 Ebola outbreak, and scanning reference lists. Includes a box of common search restrictions covering sources, language, accessible studies, grey literature, dates and region.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-206",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Screening and study selection",
      "pageStart": 158,
      "pageEnd": 158,
      "target": "../sections/sec-206-1176-screening-and-study-selection.md",
      "narrative": null,
      "content": "Standard systematic review methods apply to the process of screening the \nrecords retrieved from bibliographic databases and other searches. Records \nshould be imported into reference management software in the usual manner \nto facilitate record management and citation screening and management \nduring the drafting of the guideline document.\nAs for a standard systematic review, study selection involves a two-step \nprocess. First, two people independently screen titles and abstracts and all \npotentially relevant records, as well as records lacking enough information \nto determine their eligibili",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes screening and study selection for rapid reviews as following standard methods, with two people independently screening titles and abstracts and two reviewers assessing full texts, reaching consensus with a third reviewer if needed. Notes that one reviewer plus a check of exclusions is an acceptable alternative at the first step.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-207",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Use a stepwise approach with emphasis on higher levels of evidence",
      "pageStart": 158,
      "pageEnd": 158,
      "target": "../sections/sec-207-1177-use-a-stepwise-approach-with-emphasis-on-hi.md",
      "narrative": null,
      "content": "evidence\nTo keep the scope of the rapid reviews within the bounds dictated by timelines and resources, initially the evidence is often limited to what is found in \nsystematic reviews. If primary studies, such as RCTs, will be included, this \nneeds to be justified in the planning proposal and reflected in the timelines \nand budget. Further restrictions (e.g. by outcomes or study quality criteria) may be considered to accommodate the inclusion of primary studies. \nExcluding studies that do not report the outcomes of interest may lead to bias \nfrom selective outcome reporting. However, this is a",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends starting with evidence from systematic reviews and adding primary studies only when justified in the planning proposal and reflected in timelines and budget. Acknowledges that restricting by outcomes risks selective reporting bias but is a trade-off under time limits.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-208",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Obtaining publications",
      "pageStart": 158,
      "pageEnd": 159,
      "target": "../sections/sec-208-1178-obtaining-publications.md",
      "narrative": null,
      "content": "Records that are not available electronically are generally excluded because \nthe timeline of a rapid advice guideline is not compatible with the delays \nChapter 11 \nRapid advice guidelines in the setting of a public health emergency\n147\ninvolved in inter-library loans. WHO information scientists should be contacted before concluding that a given publication is not available, since \nWHO may have ready access to the information. Even if the full text cannot \nbe obtained or translated, the abstract may provide valuable information, \nparticularly when the evidence is sparse.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that records not available electronically are generally excluded because of time, though WHO information scientists should be consulted first and abstracts may still help when evidence is sparse.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-209",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Data extraction and evidence synthesis",
      "pageStart": 159,
      "pageEnd": 159,
      "target": "../sections/sec-209-1179-data-extraction-and-evidence-synthesis.md",
      "narrative": null,
      "content": "Before starting data extraction, it is important to carefully consider what \nspecific information the GDG will need to make its decisions so that only \nessential information is extracted. A standard extraction form should be \ndeveloped to facilitate accurate and reliable data collection, and it should be \npilot-tested. One reviewer usually extracts the data and a second one verifies \neach record. If full verification is not feasible, a random sample of at least \n10% of the included studies should be independently checked to provide \nsome measure of quality assurance. If inter-rater agreement i",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes data extraction for rapid reviews: extract only information the guideline group needs, use a pilot-tested form, and have a second reviewer verify, or check a random sample of at least 10 percent.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-210",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Assess the risk of bias at the individual study level",
      "pageStart": 159,
      "pageEnd": 160,
      "target": "../sections/sec-210-11710-assess-the-risk-of-bias-at-the-individual.md",
      "narrative": null,
      "content": "The review team should assess the risk of bias for individual studies, just as in \na standard systematic review. This step is necessary to properly interpret the \nresults of a rapid review and to use GRADE to assess the strength of the body \nof evidence for each outcome. For rapid reviews particularly, the assessment \nof the risk of bias may be used to select the studies included in the review, \nonce initial criteria based on study design have been applied.\n11.7.11 Evidence synthesis\nThe rapid review report includes, first, a summary of the overall findings of \nthe literature search and of the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that risk of bias should be assessed for individual studies and may help select studies for inclusion. Describes evidence synthesis for rapid reviews, with a PRISMA flow diagram, a narrative summary organized by PICO, stepwise extraction of effect estimates, outcome-specific synthesis, and meta-analysis only if time allows while reporting existing meta-analyses.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-211",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Assessing the quality of the body of evidence using GRADE",
      "pageStart": 160,
      "pageEnd": 162,
      "target": "../sections/sec-211-11712-assessing-the-quality-of-the-body-of-evide.md",
      "narrative": null,
      "content": "GRADE\nThe quality of the body of evidence pertaining to each outcome should be \nassessed using GRADE, as appropriate for the type of data involved (see \nChapter 9). The focus is on outcomes critical for decision-making in the context of rapid advice guidelines, and not on intermediate, surrogate or other \ntypes of outcomes. Exceptions may be made, however, when data are sparse \nand decisions need to be based on indirect evidence, including intermediate \noutcomes, for example.\nAssessments of the quality of the evidence using GRADE are not \nrestricted to cases in which pooled estimates of effect",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the quality of evidence for each outcome should be assessed with GRADE, focusing on critical outcomes, and that narrative syntheses can also be graded. Notes that modifications to standard methods can be listed under other considerations, and includes a figure on four approaches to rapid review of evidence, from summarizing one high-quality systematic review to updating one or adding primary studies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-212",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The rapid review report",
      "pageStart": 162,
      "pageEnd": 163,
      "target": "../sections/sec-212-118-the-rapid-review-report.md",
      "narrative": null,
      "content": "The review team needs to produce a concise report that succinctly yet methodically summarizes the methods used and the results of the review. Suggested \ncomponents of the rapid review report are listed in Box 11.2. All components \nshould be described briefly; excessive detail is not necessary. The rapid review \nmethods should be reported at a level of detail that will allow them to be replicated. A brief section on the gaps in the evidence and future research needs \nmay be very useful and particularly important when data are sparse. A written disclosure should be provided to the effect that th",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the concise rapid review report, which should allow replication, note evidence gaps and carry a disclosure that it is not a gold standard systematic review. Lists suggested components in a box covering introduction, methods, results, discussion, information page, references and appendices.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-213",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Formulate recommendations",
      "pageStart": 163,
      "pageEnd": 163,
      "target": "../sections/sec-213-119-formulate-recommendations.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-214",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Convene the meeting of the guideline development group",
      "pageStart": 163,
      "pageEnd": 164,
      "target": "../sections/sec-214-1191-convene-the-meeting-of-the-guideline-develo.md",
      "narrative": null,
      "content": "At the very beginning of the guideline development process, the responsible \ntechnical officer and the steering group need to plan for the GDG meeting where recommendations will be formulated. Because of the compressed \ntimeline, administrative details need to be addressed early. This includes \nidentifying a meeting space, issuing invitations to potential GDG members, \ncollecting declarations of interest and managing conflicts of interest, and \n... continued\nDiscussion\n■■\nThe strengths and limitations of the review process, focusing particularly on how \nthe methods differed from those of a sta",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the meeting of the guideline development group must be planned from the start, covering venue, invitations, declarations of interest and travel, which needs dedicated administrative support. Notes that virtual meetings are possible but an in-person meeting is generally preferable.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-215",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evidence to recommendations",
      "pageStart": 164,
      "pageEnd": 164,
      "target": "../sections/sec-215-1192-evidence-to-recommendations.md",
      "narrative": null,
      "content": "The GRADE approach for formulating recommendations should be followed \nwhen developing rapid advice guidelines (see Chapter 10). The tools used \nto translate evidence into recommendations are equally applicable to rapid \nadvice and standard guidelines. In the context of a rapid advice guideline, it \nwill seldom be feasible to collect primary data or to perform a review of the \nvalues and preferences surrounding the outcomes of interest in the guideline, nor will there be time to collect detailed information on resource use. \nHowever, data that can be readily obtained should be collected (e.g.",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that the GRADE approach and its tools apply to rapid advice guidelines, noting it is seldom feasible to collect primary data on values, preferences or resource use, though readily available data such as costs should be gathered.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-216",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Draft the guideline document",
      "pageStart": 164,
      "pageEnd": 164,
      "target": "../sections/sec-216-1110-draft-the-guideline-document.md",
      "narrative": null,
      "content": "The process and resources needed to draft the final rapid advice guideline document are essentially the same as for standard guidelines. The writer should \nbe identified early and in most situations this will be the responsible technical officer or other member(s) of the steering group. If an external contractor \nis used, he or she should be identified near the beginning of the guideline \ndevelopment process and they must be involved in all stages of the process.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the drafting of a rapid advice guideline needs the same process and resources as a standard one, with the writer, usually the technical officer or steering group member, or a contractor, identified early.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-217",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "External peer review",
      "pageStart": 164,
      "pageEnd": 165,
      "target": "../sections/sec-217-1111-external-peer-review.md",
      "narrative": null,
      "content": "Peer review of the draft of the final guideline document by key individuals, \nboth internal and external to WHO, is important for all guidelines produced by WHO, including those produced rapidly. In the context of a rapid \nChapter 11 \nRapid advice guidelines in the setting of a public health emergency\n153\n153\nadvice guideline, peer review will be accelerated and abbreviated. Early in \nthe guideline development process, the steering group should identify three \nto six key individuals and solicit their interest, availability and commitment \nto a very short turn-around time for their reviews. Lea",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that rapid advice guidelines still need accelerated, abbreviated peer review by three to six key individuals and leading external organizations, perhaps with 48 to 72 hours to respond. Says that in rare cases no peer review is possible, in which case all relevant WHO departments must at least be able to give input.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-218",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Implementation and the importance of context",
      "pageStart": 165,
      "pageEnd": 165,
      "target": "../sections/sec-218-1112-implementation-and-the-importance-of-contex.md",
      "narrative": null,
      "content": "Most evidence stemming from research is generated in settings and populations that differ from those affected by a public health emergency. Thus, the \ndegree to which such evidence may be directly applied to the current context may be limited. It is important to consider how contextual factors can \nmodify the benefits and harms of an intervention, and how various barriers \nand facilitators can affect implementation and impact. Therefore, in a rapid \nreview that relies heavily on evidence from systematic reviews, the synthesis \nshould be tailored to the local context throughout all stages of th",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that research evidence often comes from settings unlike the emergency, so contextual factors, barriers and facilitators must be considered, the synthesis tailored to the local context, and decision-makers given what they need to apply it.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-219",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Publishing",
      "pageStart": 165,
      "pageEnd": 166,
      "target": "../sections/sec-219-1113-publishing.md",
      "narrative": null,
      "content": "Preparing the final guideline document for publication involves the same \nsteps as described for a standard guideline. Electronic means will usually be \nused for initial dissemination, followed by print circulation as required in \nthe local context (see Chapter 12 and Chapter 13).\nWHO handbook for guideline development\n154\n154",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that publishing a rapid advice guideline follows the same steps as for a standard guideline, with electronic dissemination first and print as needed locally.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-220",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Updating",
      "pageStart": 166,
      "pageEnd": 166,
      "target": "../sections/sec-220-1114-updating.md",
      "narrative": null,
      "content": "All guidelines need to be kept up to date and consistent with the best available evidence. This is particularly important and difficult to achieve in the \ncontext of a public health emergency, when new data are constantly emerging and experience is continually accruing. The technical unit with primary \nresponsibility for the rapid advice guideline must keep abreast of new information and continually assess how such information might affect the recommendations given in the guideline. If data emerge to suggest that the \ncurrent recommendations need to be revised, WHO needs to be prepared to \nund",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that rapid advice guidelines must be kept up to date as new data emerge, and that their short lifespan and review-by date should be shown prominently. Discusses deciding when to replace one with a standard guideline, using the 2009 H1N1 guidance on pregnant women as an example, and notes WHO may sponsor systematic reviews to confirm high-impact recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-221",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guideline Review Committee processes for rapid advice guidelines",
      "pageStart": 166,
      "pageEnd": 167,
      "target": "../sections/sec-221-1115-guideline-review-committee-processes-for-ra.md",
      "narrative": null,
      "content": "advice guidelines\nThe GRC needs to approve the development of a rapid advice guideline. The \nappropriateness of developing a guideline in the context of a specific public \nChapter 11 \nRapid advice guidelines in the setting of a public health emergency\n155\nhealth emergency is considered when the technical unit contacts the GRC \nSecretariat; it is formally addressed when the GRC reviews the planning proposal. The planning proposal must provide adequate justification for applying an accelerated and abbreviated process; prolonged emergencies that call \nfor a rapid advance guideline are uncommon.\nT",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the Guideline Review Committee's role: it must approve development of a rapid advice guideline, judging appropriateness through the planning proposal, and review the final guideline. Says the handbook's principles still apply with case-by-case exceptions, and that the committee provides expedited reviews and ad hoc meetings.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-222",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Conclusions",
      "pageStart": 167,
      "pageEnd": 168,
      "target": "../sections/sec-222-1116-conclusions.md",
      "narrative": null,
      "content": "This chapter outlines the processes and methods used to develop a rapid \nadvice guideline within one to three months in the context of a public health \nemergency. The development of a rapid advance guideline differs in important ways from the development of a standard guideline. Unlike a standard \nguideline, a rapid advice guideline must have a very narrow scope to make \ndevelopment feasible within the given time frame. Moreover, WHO staff \nand external experts must be identified and engaged from the very beginning of the guideline development process, and the GRC Secretariat must \nbe contacte",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Concludes that rapid advice guidelines are developed in one to three months with a very narrow scope, early engagement of experts and the review committee Secretariat, and more fluid evidence review methods. Stresses that core principles of minimizing bias, transparency and meeting audience needs still apply, and that limitations and a commitment to update must be stated.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-223",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 168,
      "pageEnd": 169,
      "target": "../sections/sec-223-1117-references.md",
      "narrative": null,
      "content": "1.\t\nKhangura S, Konnyu K, Cushman R, Grimshaw J, Moher D. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1(1):10.\n2.\t\nWatt A, Cameron A, Sturm L, Lathlean T, Babidge W, Blamey S, et al. Rapid reviews versus \nfull systematic reviews: an inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24(2):133–9. doi: http://dx.doi.\norg/10.1017/S0266462308080185 PMID: 18400114\n3.\t\nGanann R, Ciliska D, Thomas H. Expediting systematic reviews: methods and implications \nof rapid reviews. Implement Sci. 2010;5(1):56. doi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list of publications and WHO documents cited in the chapter on rapid advice guidelines, followed by the opening lines of the next chapter on producing and publishing the guideline, which begin a list of what needs coordinating.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-224",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Peer review",
      "pageStart": 169,
      "pageEnd": 169,
      "target": "../sections/sec-224-122-peer-review.md",
      "narrative": null,
      "content": "■■\nfollowing WHO’s production and publication processes;\n■■\ndisseminating the guideline; and\n■■\nupdating its contents.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A short fragment of bullets continuing a list (following WHO production and publication processes, disseminating and updating the guideline), filed under a peer review heading.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-225",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guideline format",
      "pageStart": 169,
      "pageEnd": 171,
      "target": "../sections/sec-225-121-guideline-format.md",
      "narrative": null,
      "content": "All guidelines should have an executive summary, a main body and appendices. The executive summary should contain the key recommendations of the \nguideline. As executive summaries are often read as stand-alone documents, \nthe strength of the recommendation and the quality of the evidence for each \nrecommendation should be specified in the executive summary, as well as in \nthe main body of the guideline. Authors may wish to note contextual issues \nfor each recommendation and include a brief methods section and citations, \nalthough these are not required.\nThe main text of the guideline should in",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the required guideline format: an executive summary with key recommendations, strength and evidence quality, a main body with introduction, methods, recommendations, conclusions and participant and interest details, and appendices for supporting documentation. Also covers use of PRISMA and the AGREE-II appraisal before clearance, and begins the peer review section, stating that WHO guidelines must undergo peer review by the external review group and WHO departments, with changes limited at that stage. Text under this heading therefore extends into the next section.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-226",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Producing and publishing the guideline",
      "pageStart": 171,
      "pageEnd": 171,
      "target": "../sections/sec-226-12-producing-and-publishing-the-guideline.md",
      "narrative": null,
      "content": "159\n159\n■■\nSystematic review protocols outlining the search strategy, study eligibility criteria and research synthesis methods can be circulated to \nmembers of the external review group for comments.\n■■\nThe list of included studies identified by searching bibliographic databases \ncan be sent to technical experts to look for studies that have been missed.\n■■\nDraft evidence profiles can be circulated to experts, again for the identification of missing data.\nAll WHO guidelines require some form of external peer review of the \ndraft final guideline. Because of the time constraints in the developm",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists ways to involve external reviewers earlier, such as circulating systematic review protocols, lists of included studies and draft evidence profiles, and states that all guidelines need external peer review, with a few reviewers and short turn-around for rapid advice guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-227",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The production process",
      "pageStart": 171,
      "pageEnd": 171,
      "target": "../sections/sec-227-123-the-production-process.md",
      "narrative": null,
      "content": "Production of WHO guidelines should follow the same process as for other \nWHO publications. Detailed information on each step is available to WHO \nstaff on the WHO intranet (3). A brief overview is provided here.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the guideline production process, which follows the same steps as other WHO publications, with details on the staff intranet and a brief overview given here.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-228",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Writing",
      "pageStart": 171,
      "pageEnd": 172,
      "target": "../sections/sec-228-1231-writing.md",
      "narrative": null,
      "content": "Identify a writer early in the process and make sure this person is engaged \nthroughout the guideline’s development. The writer can be a WHO staff \nmember or contracted on a freelance basis. In either case, it is important \nto accurately estimate the demands that will be made on the person’s time. \nOnce you have an idea of the approximate length of your document, you can \nroughly calculate the time needed and can begin negotiations with an external writer if necessary. WHO does not have a standard pay scale for writing, \nbut WHO Press usually advises a minimum of US$ 0.50 per word for writers,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises identifying a writer early, whether staff or freelance, estimating time and fees, with guidance on rates and a week for 5000 words. Recommends avoiding multiple authors, since unpaid chapter drafts tend to create more work.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-229",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Legal advice on proprietary products",
      "pageStart": 172,
      "pageEnd": 172,
      "target": "../sections/sec-229-1232-legal-advice-on-proprietary-products.md",
      "narrative": null,
      "content": "WHO guidelines should avoid specifying proprietary products when at all \npossible. Devices and diagnostics used in interventions should be described \ngenerically to avoid identification of specific products and trademarks. If in \ndoubt, please contact WHO’s legal counsel.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises that guidelines should avoid naming proprietary products, describing devices and diagnostics generically and consulting WHO legal counsel if in doubt.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-230",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Editing and proofreading",
      "pageStart": 172,
      "pageEnd": 172,
      "target": "../sections/sec-230-1233-editing-and-proofreading.md",
      "narrative": null,
      "content": "You will also need an editor and a proofreader. WHO press maintains lists of \napproved freelance technical editors, copy-editors and proofreaders and provides \nsample terms of reference and standard rates of pay for these tasks on the intranet. \nThe best editors and proofreaders are often booked up many months in advance, so \nplan production schedules as early as possible and reserve their time accordingly.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises engaging an editor and proofreader from lists kept by the publishing office, and booking them early because the best are reserved months ahead.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-231",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Executive clearance and approval by the Guideline Review Committee",
      "pageStart": 172,
      "pageEnd": 172,
      "target": "../sections/sec-231-1234-executive-clearance-and-approval-by-the-gui.md",
      "narrative": null,
      "content": "Committee\nGRC review of final guideline documents occurs as part of the final executive \nclearance. In headquarters, submission to the GRC is done after approval by \nthe relevant director and before submission to the assistant director-general.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Says the Guideline Review Committee reviews final guideline documents as part of executive clearance, after the relevant director's approval and before the assistant director-general.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-232",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Layout",
      "pageStart": 172,
      "pageEnd": 172,
      "target": "../sections/sec-232-1235-layout.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-233",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Printing",
      "pageStart": 172,
      "pageEnd": 173,
      "target": "../sections/sec-233-1236-printing.md",
      "narrative": null,
      "content": "12.3.5 Layout\nOnce you have an edited and carefully checked manuscript that has received \nfull executive clearance from the relevant assistant director-general, you will \nneed to send it for layout. Again, WHO Press can advise on external typesetters and the specifications that you should include when contracting for this \nwork. The WHO graphics team also provides an internal layout service. As \nmany design decisions have major implications for the cost of production, \nprinting, dissemination and subsequent translations, it is worth using existing publication templates if your department has e",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the layout and printing steps after executive clearance: using external typesetters or the graphics team and existing templates, then obtaining a cover, ISBN and barcode. Explains that the publishing office arranges printing quotes and print runs and that the proofreader should check the printer's proofs.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-234",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Disseminating guidelines",
      "pageStart": 173,
      "pageEnd": 173,
      "target": "../sections/sec-234-124-disseminating-guidelines.md",
      "narrative": null,
      "content": "Dissemination involves making guidelines accessible, advertising their \navailability and distributing them widely. Guideline developers should consult with WHO Press on priced and mandatory free distribution. Priced distribution is done by WHO Press through sales agents in all regions and by \nthe WHO bookshop. The extent of mandatory free distribution depends on \nthe type of publication but can include depository libraries, schools of public \nhealth, schools of medicine, WHO country offices and missions in Geneva. \nPlease consult with WHO Press on the number of print copies required for \nmanda",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that dissemination means making guidelines accessible, advertising them and distributing them, with priced distribution through sales agents and the bookshop and mandatory free distribution to bodies such as libraries and country offices, to be planned with the publishing office.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-235",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Online publication",
      "pageStart": 173,
      "pageEnd": 174,
      "target": "../sections/sec-235-1241-online-publication.md",
      "narrative": null,
      "content": "Your guideline can appear on the Internet in a variety of formats. At a minimum, you should contract your designer or typesetter to produce a web-\nready portable document format (PDF) – a smaller file size than the PDFs \nproduced for print – that is easier to download and navigate. Depending on \nthe length of the guideline and its intended audience, you may also wish to \nconsider providing full-text hypertext mark-up language (HTML) and additional materials, both electronic and printed. The WHO web team is a good \nsource of advice.\nWHO handbook for guideline development\n162\n162",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises producing at least a web-ready PDF of the guideline, possibly with HTML and extra materials, and consulting the WHO web team.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-236",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Archiving",
      "pageStart": 174,
      "pageEnd": 174,
      "target": "../sections/sec-236-1242-archiving.md",
      "narrative": null,
      "content": "At the time of publication, the department should ensure that archiving \nrequirements are met. In headquarters, departments should send the final \nelectronic file of their guideline to the WHO Library for inclusion in the Institutional Repository for Information Sharing (IRIS) (4). In regional offices, \ndepartments should send the final electronic file of their information products to their regional office library. If printed copies are produced, one should \nalso be sent for inclusion in the print collection of the respective library.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes archiving requirements: departments send the final electronic file to the WHO Library repository, or regional office library, with a printed copy for the print collection if produced.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-237",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Translations",
      "pageStart": 174,
      "pageEnd": 174,
      "target": "../sections/sec-237-1243-translations.md",
      "narrative": null,
      "content": "Because WHO guidelines target a global audience, it is often necessary to \nprovide the guideline in one or several languages, particularly the six official languages; Arabic, Chinese, English, French, Russian and Spanish. To \nensure accurate translation of technical content, experts should be involved \nin checking the translations. Translations must be planned in advance \nand their timing discussed with the translation suppliers or regional office \ninvolved. Do not forget to budget for translation costs. To reduce such costs, \ntranslations may be limited to the executive summaries. Special car",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that translations, particularly into the six official languages, should be planned and budgeted, with experts checking technical content. Notes that translating only executive summaries can cut costs and that the meaning and strength of recommendations must not change.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-238",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Journals",
      "pageStart": 174,
      "pageEnd": 174,
      "target": "../sections/sec-238-1244-journals.md",
      "narrative": null,
      "content": "The systematic reviews commissioned for the guideline may be submitted for \npublication in the Bulletin of the World Health Organization or other journals. Cochrane reviews are published in the Cochrane Library. To increase \nawareness of the guideline, the guideline development process and/or recommendations may also be published in peer-reviewed journals, in compliance \nwith WHO’s open access and copyright policies. All external publications \nwith WHO authors require internal clearance.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the commissioned systematic reviews and the guideline's process or recommendations may be published in journals, within open access and copyright policy, and that external publications with WHO authors require internal clearance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-239",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Other forms of dissemination",
      "pageStart": 174,
      "pageEnd": 175,
      "target": "../sections/sec-239-1245-other-forms-of-dissemination.md",
      "narrative": null,
      "content": "You should carefully plan a dissemination strategy early in the development \nprocess. A variety of approaches should be considered. These can include an offi\nChapter 12 \nProducing and publishing the guideline\n163\n163\ncial launch, a press release and/or conference, an announcement on the WHO \nwebsite, distribution through regional offices or at meetings, and endorsement \nby stakeholders and interest groups. Mobile phone applications for guideline \ndissemination and decision support can also be commissioned. Because the \nguideline document itself may be quite lengthy, more succinct derivative pr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Advises planning a dissemination strategy early, using launches, press releases, web announcements, regional distribution, stakeholder endorsement and mobile applications, and preparing shorter derivative products such as charts and manuals.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-240",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Updating guideline",
      "pageStart": 175,
      "pageEnd": 175,
      "target": "../sections/sec-240-125-updating-guideline.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-241",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Review-by date",
      "pageStart": 175,
      "pageEnd": 175,
      "target": "../sections/sec-241-1251-review-by-date.md",
      "narrative": null,
      "content": "WHO guidelines should be issued with a “review-by” date to indicate how long the \nrecommendations are expected to remain valid. There is no absolute rule about \nthe length of validity (5, 6). In deciding on the date by which a guideline should be \nreviewed, take account of the rate of change of research on the topic, questions for \nwhich no evidence has been found, and the potential need for new advice.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that guidelines should carry a review-by date showing how long recommendations are expected to stay valid, set by considering the pace of research, questions without evidence and the potential need for new advice.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-242",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Updating recommendations",
      "pageStart": 175,
      "pageEnd": 175,
      "target": "../sections/sec-242-1252-updating-recommendations.md",
      "narrative": null,
      "content": "All WHO recommendations that are not based on the processes and standards outlined in this handbook (particularly those published before the GRC \nwas established in 2007 and those not considering equity, human rights and \ngender) should be updated to meet current WHO guideline standards. Updating guidelines is challenging if evidence has to be retrieved to support a large \nnumber of existing recommendations. In this situation it is important to give \npriority to controversial areas, or those in which new evidence has emerged. If \nrecommendations will be updated incrementally, the planned appro",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that recommendations not developed under the handbook's standards, especially those predating the review committee's 2007 creation or ignoring equity, human rights and gender, should be updated. Advises prioritizing controversial areas or those with new evidence, and discussing incremental updating with the committee Secretariat.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-243",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Guidelines that are near or beyond their “review-by” date",
      "pageStart": 175,
      "pageEnd": 176,
      "target": "../sections/sec-243-1253-guidelines-that-are-near-or-beyond-their-re.md",
      "narrative": null,
      "content": "Technical units are responsible for keeping their guidelines up to date. As \nguidelines near their “review-by” date, they should be carefully examined \nfor currency. If there is reason to believe one or more recommendations need \nupdating, plans should be made to start that process.\nWHO handbook for guideline development\n164\n164",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that technical units are responsible for examining guidelines for currency as the review-by date approaches and planning updates where recommendations may need changing.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-244",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Recommendations that may be out of date",
      "pageStart": 176,
      "pageEnd": 176,
      "target": "../sections/sec-244-1254-recommendations-that-may-be-out-of-date.md",
      "narrative": null,
      "content": "Occasionally guideline developers may want to update guidelines before the \n“review-by” date, particularly if new evidence is published. This new evidence \nshould always be seen in the context of the total body of evidence supporting \nthe recommendations and thus should be part of a new or updated systematic review. Any update that involves changing recommendations needs to be \nreviewed by the GRC. Updates that add new evidence without changing the recommendations do not require review, although under certain circumstances, if \nthe topic or new evidence is highly controversial, GRC review may",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that early updates should be based on the total body of evidence through a new or updated systematic review, and that changing recommendations requires committee review while adding evidence alone does not. Says stakeholders should be told when recommendations may be invalid and updates are planned.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-245",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 176,
      "pageEnd": 177,
      "target": "../sections/sec-245-126-references.md",
      "narrative": null,
      "content": "1.\t\nMoher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting \nitems for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. \n2009;6(7):e1000097. doi: http://dx.doi.org/10.1371/journal.pmed.1000097 PMID: 19621072\n2.\t\nBrouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al.; AGREE Next \nSteps Consortium. AGREE II: advancing guideline development, reporting and evaluation \nin health care. CMAJ. 2010;182(18):E839–42. doi: http://dx.doi.org/10.1503/cmaj.090449 \nPMID: 20603348\n3.\t\nWHO eManual/VIII - Information Products [intranet site: available",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list of publications cited in the chapter on producing and publishing the guideline, including PRISMA, AGREE II and papers on when guidelines should be updated.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-246",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Adaptation, implementation and evaluation",
      "pageStart": 177,
      "pageEnd": 178,
      "target": "../sections/sec-246-13-adaptation-implementation-and-evaluation.md",
      "narrative": null,
      "content": "guideline development process. The implementation of new guidance gives \nrise to new evidence of impact and new research questions. Practice needs to \nbe continually re-evaluated, and guidance updated in light of new evidence. \nAlthough implementation and evaluation plans do not need to be described \nin the guideline, they should be considered by the steering group, made \navailable to all guideline contributors and actively supported by the department authoring the guideline. The steering group and GDG should discuss \nand document a list of the tools and resources that will need to be made \nav",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how adaptation, implementation and evaluation should be considered during development, including tools and resources for countries and partners who will lead adaptation. Explains adaptation to local circumstances at regional, national or subnational level and that implementation is context-specific and the responsibility of national or subnational groups, supported by WHO offices through promotion, workshops, tools and coordination. Section text begins mid-sentence because extraction dropped the chapter's opening heading.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-247",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Monitoring and evaluation",
      "pageStart": 178,
      "pageEnd": 179,
      "target": "../sections/sec-247-133-monitoring-and-evaluation.md",
      "narrative": null,
      "content": "Monitoring and evaluation systems are used to collect and analyse data to \nassess the effectiveness and impact of the guideline. The guideline should \ninclude outcome or performance measures that can be monitored for the \nmain recommendations. Performance measures may be related to:\n■■\nguideline dissemination;\n■■\nadaptation and endorsement in the national context;\nChapter 13 \nAdaptation, implementation and evaluation\n167\n167\n■■\npolicy changes;\n■■\nchanges in end-user knowledge and understanding;\n■■\nchanges in practice performance;\n■■\nchanges in health outcomes and inequities (both by level and",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that monitoring and evaluation assess a guideline's effectiveness and impact, and that guidelines should include performance measures such as dissemination, adaptation, policy changes, knowledge, practice, health outcomes and equity, and costs. Recommends baseline measures, implementation research and a specific set of indicators with disaggregation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    },
    {
      "id": "library/9789241548960-eng/blocks/prose-sec-248",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 179,
      "pageEnd": 179,
      "target": "../sections/sec-248-134-references.md",
      "narrative": null,
      "content": "1.\t\nBryce J, Victora CG, Habicht JP, Vaughan JP, Black RE. The multi-country evaluation of the \nintegrated management of childhood illness strategy: lessons for the evaluation of public \nhealth interventions. Am J Public Health. 2004;94(3):406–15. doi: http://dx.doi.org/10.2105/\nAJPH.94.3.406 PMID: 14998804\n2.\t\nADAPTE Collaboration. The ADAPTE Manual for Guideline Adaptation. Version 1.0. Guidelines \nInternational Network; 2007 (http://www.g-i-n.net/document-store/working-groups-\ndocuments/adaptation/adapte-manual-for-guideline.pdf, accessed 12 November 2014).",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list with two items, on the multicountry evaluation of Integrated Management of Childhood Illness and the ADAPTE manual for guideline adaptation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-06"
      }
    }
  ]
}
